PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf4
|
ENSMUSG00000003032.9 | Klf4 |
Sp3
|
ENSMUSG00000027109.17 | Sp3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf4 | mm39_v1_chr4_-_55532453_55532485 | 0.78 | 3.6e-16 | Click! |
Sp3 | mm39_v1_chr2_-_72810782_72810811 | 0.49 | 9.9e-06 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_113115632 | 33.19 |
ENSMUST00000006523.12
ENSMUST00000200553.2 |
Crip1
|
cysteine-rich protein 1 (intestinal) |
chr6_-_72935171 | 29.46 |
ENSMUST00000114049.2
|
Tmsb10
|
thymosin, beta 10 |
chr7_-_80453033 | 27.76 |
ENSMUST00000167377.3
|
Iqgap1
|
IQ motif containing GTPase activating protein 1 |
chr3_+_90520408 | 26.65 |
ENSMUST00000198128.2
|
S100a6
|
S100 calcium binding protein A6 (calcyclin) |
chr6_-_72935382 | 25.59 |
ENSMUST00000144337.2
|
Tmsb10
|
thymosin, beta 10 |
chr11_-_100036792 | 25.08 |
ENSMUST00000007317.8
|
Krt19
|
keratin 19 |
chr5_-_114046746 | 24.88 |
ENSMUST00000004646.13
|
Coro1c
|
coronin, actin binding protein 1C |
chr4_+_62398262 | 24.18 |
ENSMUST00000030088.12
ENSMUST00000107449.4 |
Bspry
|
B-box and SPRY domain containing |
chr6_-_72935468 | 23.67 |
ENSMUST00000114050.8
|
Tmsb10
|
thymosin, beta 10 |
chrX_-_73289970 | 23.57 |
ENSMUST00000130007.8
|
Flna
|
filamin, alpha |
chr8_+_106245368 | 23.46 |
ENSMUST00000034363.7
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2 |
chr19_+_38043446 | 23.31 |
ENSMUST00000236044.2
ENSMUST00000116506.8 ENSMUST00000096096.12 ENSMUST00000169673.3 |
Cep55
|
centrosomal protein 55 |
chr17_+_57556449 | 22.96 |
ENSMUST00000224947.2
ENSMUST00000019631.11 ENSMUST00000224885.2 ENSMUST00000224152.2 |
Trip10
|
thyroid hormone receptor interactor 10 |
chr1_+_136059101 | 22.66 |
ENSMUST00000075164.11
|
Kif21b
|
kinesin family member 21B |
chr2_-_163592127 | 22.34 |
ENSMUST00000017841.4
|
Ada
|
adenosine deaminase |
chr7_-_19363280 | 22.25 |
ENSMUST00000094762.10
ENSMUST00000049912.15 ENSMUST00000098754.5 |
Relb
|
avian reticuloendotheliosis viral (v-rel) oncogene related B |
chrX_-_73290140 | 22.04 |
ENSMUST00000101454.9
ENSMUST00000033699.13 |
Flna
|
filamin, alpha |
chr4_-_133615075 | 21.19 |
ENSMUST00000003741.16
ENSMUST00000105894.11 |
Rps6ka1
|
ribosomal protein S6 kinase polypeptide 1 |
chr8_-_106198112 | 21.03 |
ENSMUST00000014990.13
|
Tppp3
|
tubulin polymerization-promoting protein family member 3 |
chr15_-_97806142 | 20.77 |
ENSMUST00000023119.15
|
Vdr
|
vitamin D (1,25-dihydroxyvitamin D3) receptor |
chr9_-_21829385 | 20.37 |
ENSMUST00000128442.2
ENSMUST00000119055.8 ENSMUST00000122211.8 ENSMUST00000115351.10 |
Rab3d
|
RAB3D, member RAS oncogene family |
chr6_-_86646118 | 20.24 |
ENSMUST00000001184.10
|
Mxd1
|
MAX dimerization protein 1 |
chr4_-_55532453 | 20.10 |
ENSMUST00000132746.2
ENSMUST00000107619.3 |
Klf4
|
Kruppel-like factor 4 (gut) |
chr17_+_31783708 | 20.09 |
ENSMUST00000097352.11
ENSMUST00000237248.2 ENSMUST00000235869.2 ENSMUST00000175806.9 |
Pknox1
|
Pbx/knotted 1 homeobox |
chr7_+_16515265 | 19.53 |
ENSMUST00000108496.9
|
Slc1a5
|
solute carrier family 1 (neutral amino acid transporter), member 5 |
chr7_-_4755971 | 19.13 |
ENSMUST00000183971.8
ENSMUST00000182173.2 ENSMUST00000182738.8 ENSMUST00000182111.8 ENSMUST00000184143.8 ENSMUST00000182048.2 ENSMUST00000063324.14 |
Cox6b2
|
cytochrome c oxidase subunit 6B2 |
chr19_+_6952580 | 19.02 |
ENSMUST00000237084.2
ENSMUST00000236218.2 ENSMUST00000237235.2 |
Ppp1r14b
|
protein phosphatase 1, regulatory inhibitor subunit 14B |
chr4_+_137196080 | 18.80 |
ENSMUST00000030547.15
ENSMUST00000171332.2 |
Hspg2
|
perlecan (heparan sulfate proteoglycan 2) |
chr10_+_79824418 | 18.67 |
ENSMUST00000004784.11
ENSMUST00000105374.2 |
Cnn2
|
calponin 2 |
chr19_+_6952319 | 18.61 |
ENSMUST00000070850.8
|
Ppp1r14b
|
protein phosphatase 1, regulatory inhibitor subunit 14B |
chr7_+_79944198 | 18.42 |
ENSMUST00000163812.9
ENSMUST00000047558.14 ENSMUST00000174199.8 ENSMUST00000173824.8 ENSMUST00000174172.8 |
Prc1
|
protein regulator of cytokinesis 1 |
chr17_+_35133435 | 18.39 |
ENSMUST00000007249.15
|
Slc44a4
|
solute carrier family 44, member 4 |
chr11_+_72851989 | 18.29 |
ENSMUST00000163326.8
ENSMUST00000108485.9 ENSMUST00000021142.8 ENSMUST00000108486.8 ENSMUST00000108484.8 |
Atp2a3
|
ATPase, Ca++ transporting, ubiquitous |
chr7_-_25516041 | 18.01 |
ENSMUST00000043314.10
|
Cyp2s1
|
cytochrome P450, family 2, subfamily s, polypeptide 1 |
chr5_-_144294854 | 17.76 |
ENSMUST00000055190.8
|
Baiap2l1
|
BAI1-associated protein 2-like 1 |
chr13_-_95661726 | 17.67 |
ENSMUST00000022185.10
|
F2rl1
|
coagulation factor II (thrombin) receptor-like 1 |
chr7_-_16019935 | 17.32 |
ENSMUST00000145519.3
|
Ccdc9
|
coiled-coil domain containing 9 |
chr9_-_31043076 | 17.27 |
ENSMUST00000034478.3
|
St14
|
suppression of tumorigenicity 14 (colon carcinoma) |
chr7_+_100142544 | 17.21 |
ENSMUST00000126534.8
ENSMUST00000207748.2 |
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr17_+_29709723 | 17.16 |
ENSMUST00000024811.9
|
Pim1
|
proviral integration site 1 |
chr18_+_50112494 | 17.10 |
ENSMUST00000148989.3
|
Tnfaip8
|
tumor necrosis factor, alpha-induced protein 8 |
chr11_-_3489228 | 16.97 |
ENSMUST00000075118.10
ENSMUST00000136243.2 ENSMUST00000020721.15 ENSMUST00000170588.8 |
Smtn
|
smoothelin |
chr15_-_5273659 | 16.93 |
ENSMUST00000047379.15
|
Ptger4
|
prostaglandin E receptor 4 (subtype EP4) |
chr11_-_69786324 | 16.93 |
ENSMUST00000001631.7
|
Acap1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr17_-_7050145 | 16.89 |
ENSMUST00000064234.7
|
Ezr
|
ezrin |
chr3_-_100396635 | 16.87 |
ENSMUST00000061455.9
|
Tent5c
|
terminal nucleotidyltransferase 5C |
chr2_-_91854844 | 16.77 |
ENSMUST00000028663.5
|
Creb3l1
|
cAMP responsive element binding protein 3-like 1 |
chr2_-_164197987 | 16.73 |
ENSMUST00000165980.2
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr11_-_116515026 | 16.63 |
ENSMUST00000103029.10
|
Rhbdf2
|
rhomboid 5 homolog 2 |
chr7_+_140659672 | 16.61 |
ENSMUST00000066873.5
ENSMUST00000163041.2 |
Pkp3
|
plakophilin 3 |
chr1_-_64776890 | 16.46 |
ENSMUST00000116133.4
ENSMUST00000063982.7 |
Fzd5
|
frizzled class receptor 5 |
chr3_+_68912302 | 16.35 |
ENSMUST00000136502.8
ENSMUST00000107803.7 |
Smc4
|
structural maintenance of chromosomes 4 |
chr15_-_5273645 | 16.34 |
ENSMUST00000120563.2
|
Ptger4
|
prostaglandin E receptor 4 (subtype EP4) |
chr1_-_180641159 | 16.33 |
ENSMUST00000162118.8
ENSMUST00000159685.2 ENSMUST00000161308.8 |
H3f3a
|
H3.3 histone A |
chr14_-_30348153 | 16.24 |
ENSMUST00000112211.9
ENSMUST00000112210.11 |
Prkcd
|
protein kinase C, delta |
chr18_+_50112580 | 16.13 |
ENSMUST00000179937.2
|
Tnfaip8
|
tumor necrosis factor, alpha-induced protein 8 |
chr10_+_81228877 | 16.02 |
ENSMUST00000105322.9
|
Smim24
|
small integral membrane protein 24 |
chr2_-_169973076 | 16.02 |
ENSMUST00000063710.13
|
Zfp217
|
zinc finger protein 217 |
chr1_+_172327569 | 15.97 |
ENSMUST00000111230.8
|
Tagln2
|
transgelin 2 |
chr12_+_17740831 | 15.92 |
ENSMUST00000071858.5
|
Hpcal1
|
hippocalcin-like 1 |
chr11_+_117740077 | 15.89 |
ENSMUST00000081387.11
|
Birc5
|
baculoviral IAP repeat-containing 5 |
chr7_+_100142977 | 15.77 |
ENSMUST00000129324.8
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr7_-_19362328 | 15.71 |
ENSMUST00000141586.2
ENSMUST00000153309.8 |
Relb
|
avian reticuloendotheliosis viral (v-rel) oncogene related B |
chr1_-_71142305 | 15.55 |
ENSMUST00000027393.8
|
Bard1
|
BRCA1 associated RING domain 1 |
chr4_+_111577172 | 15.54 |
ENSMUST00000038868.14
ENSMUST00000070513.13 ENSMUST00000153746.8 |
Spata6
|
spermatogenesis associated 6 |
chr6_+_72526236 | 15.46 |
ENSMUST00000114071.8
|
Capg
|
capping protein (actin filament), gelsolin-like |
chr15_+_25622611 | 15.31 |
ENSMUST00000110457.8
ENSMUST00000137601.8 |
Myo10
|
myosin X |
chr17_-_28569574 | 15.31 |
ENSMUST00000114799.8
ENSMUST00000219703.3 |
Tead3
|
TEA domain family member 3 |
chr18_-_42084249 | 15.21 |
ENSMUST00000070949.6
ENSMUST00000235606.2 |
Prelid2
|
PRELI domain containing 2 |
chr4_+_111577382 | 15.16 |
ENSMUST00000084354.4
|
Spata6
|
spermatogenesis associated 6 |
chr11_-_75918551 | 15.06 |
ENSMUST00000021207.7
|
Rflnb
|
refilin B |
chr9_+_22010512 | 14.98 |
ENSMUST00000214601.2
ENSMUST00000001384.6 |
Cnn1
|
calponin 1 |
chr9_+_69360902 | 14.97 |
ENSMUST00000034756.15
ENSMUST00000123470.8 |
Anxa2
|
annexin A2 |
chr8_+_120719177 | 14.95 |
ENSMUST00000132583.8
ENSMUST00000034282.16 |
Crispld2
|
cysteine-rich secretory protein LCCL domain containing 2 |
chr12_-_69274936 | 14.76 |
ENSMUST00000221411.2
ENSMUST00000021359.7 |
Pole2
|
polymerase (DNA directed), epsilon 2 (p59 subunit) |
chr2_-_164198427 | 14.75 |
ENSMUST00000109367.10
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr9_+_69361348 | 14.59 |
ENSMUST00000134907.8
|
Anxa2
|
annexin A2 |
chr13_+_35925296 | 14.58 |
ENSMUST00000163595.3
|
Cdyl
|
chromodomain protein, Y chromosome-like |
chr3_+_68912043 | 14.55 |
ENSMUST00000042901.15
|
Smc4
|
structural maintenance of chromosomes 4 |
chr8_+_57964921 | 14.49 |
ENSMUST00000067925.8
|
Hmgb2
|
high mobility group box 2 |
chr12_+_113112311 | 14.46 |
ENSMUST00000199089.5
|
Crip1
|
cysteine-rich protein 1 (intestinal) |
chr4_+_101504938 | 14.44 |
ENSMUST00000106927.2
|
Leprot
|
leptin receptor overlapping transcript |
chr15_+_100513230 | 14.40 |
ENSMUST00000000356.10
|
Dazap2
|
DAZ associated protein 2 |
chr8_+_57964956 | 14.22 |
ENSMUST00000210871.2
|
Hmgb2
|
high mobility group box 2 |
chr10_-_12839995 | 14.21 |
ENSMUST00000219727.2
ENSMUST00000163425.9 ENSMUST00000042861.7 ENSMUST00000218685.2 |
Stx11
|
syntaxin 11 |
chr7_-_19483389 | 14.14 |
ENSMUST00000108450.5
ENSMUST00000075447.14 |
Nectin2
|
nectin cell adhesion molecule 2 |
chr3_+_122523219 | 14.13 |
ENSMUST00000200389.2
|
Pde5a
|
phosphodiesterase 5A, cGMP-specific |
chr2_+_119068012 | 14.02 |
ENSMUST00000110817.3
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr2_+_119067832 | 14.01 |
ENSMUST00000028783.14
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr19_-_17333972 | 13.98 |
ENSMUST00000174236.8
|
Gcnt1
|
glucosaminyl (N-acetyl) transferase 1, core 2 |
chr11_+_69826603 | 13.84 |
ENSMUST00000018698.12
|
Ybx2
|
Y box protein 2 |
chr4_-_133329479 | 13.84 |
ENSMUST00000057311.4
|
Sfn
|
stratifin |
chr17_+_34134873 | 13.83 |
ENSMUST00000172619.8
ENSMUST00000174463.2 |
Tapbp
Zbtb22
|
TAP binding protein zinc finger and BTB domain containing 22 |
chr7_+_24069680 | 13.80 |
ENSMUST00000205428.2
ENSMUST00000171904.3 ENSMUST00000205626.2 |
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr13_-_74956030 | 13.77 |
ENSMUST00000065629.6
|
Cast
|
calpastatin |
chr19_+_6135013 | 13.77 |
ENSMUST00000025704.3
|
Cdca5
|
cell division cycle associated 5 |
chr11_-_117859997 | 13.72 |
ENSMUST00000054002.4
|
Socs3
|
suppressor of cytokine signaling 3 |
chr1_-_180641099 | 13.71 |
ENSMUST00000159789.2
ENSMUST00000081026.11 |
H3f3a
|
H3.3 histone A |
chr11_-_100288566 | 13.71 |
ENSMUST00000001592.15
ENSMUST00000107403.2 |
Jup
|
junction plakoglobin |
chr15_-_85918378 | 13.69 |
ENSMUST00000016172.10
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1 |
chr8_-_36293588 | 13.57 |
ENSMUST00000060128.7
|
Cldn23
|
claudin 23 |
chr4_-_40853950 | 13.53 |
ENSMUST00000030121.13
ENSMUST00000108096.3 |
B4galt1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
chr1_+_192835414 | 13.47 |
ENSMUST00000076521.7
|
Irf6
|
interferon regulatory factor 6 |
chr9_+_7764042 | 13.41 |
ENSMUST00000052865.16
|
Tmem123
|
transmembrane protein 123 |
chr17_+_36172210 | 13.39 |
ENSMUST00000074259.15
ENSMUST00000174873.2 |
Nrm
|
nurim (nuclear envelope membrane protein) |
chr12_+_112611069 | 13.20 |
ENSMUST00000021728.12
|
Siva1
|
SIVA1, apoptosis-inducing factor |
chr10_+_79855454 | 13.14 |
ENSMUST00000043311.7
|
Arhgap45
|
Rho GTPase activating protein 45 |
chr4_-_43523595 | 13.10 |
ENSMUST00000107914.10
|
Tpm2
|
tropomyosin 2, beta |
chr10_-_5755412 | 13.05 |
ENSMUST00000019907.8
|
Fbxo5
|
F-box protein 5 |
chr17_-_28569721 | 12.99 |
ENSMUST00000156862.3
|
Tead3
|
TEA domain family member 3 |
chr5_+_52898910 | 12.99 |
ENSMUST00000031081.11
ENSMUST00000031082.8 |
Pi4k2b
|
phosphatidylinositol 4-kinase type 2 beta |
chr1_+_172327812 | 12.97 |
ENSMUST00000192460.2
|
Tagln2
|
transgelin 2 |
chr3_-_127689890 | 12.94 |
ENSMUST00000057198.9
ENSMUST00000199273.2 |
Fam241a
|
family with sequence similarity 241, member A |
chr18_+_67422256 | 12.91 |
ENSMUST00000025403.8
|
Impa2
|
inositol monophosphatase 2 |
chr9_-_71499547 | 12.86 |
ENSMUST00000169573.8
|
Myzap
|
myocardial zonula adherens protein |
chr13_+_47196975 | 12.81 |
ENSMUST00000037025.16
ENSMUST00000143868.2 |
Kdm1b
|
lysine (K)-specific demethylase 1B |
chr2_+_119067929 | 12.77 |
ENSMUST00000110816.8
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr10_+_81229443 | 12.75 |
ENSMUST00000118206.2
|
Smim24
|
small integral membrane protein 24 |
chr7_+_35033595 | 12.68 |
ENSMUST00000032705.13
ENSMUST00000085556.4 |
Rhpn2
|
rhophilin, Rho GTPase binding protein 2 |
chr11_+_105858764 | 12.65 |
ENSMUST00000001963.14
|
Ace
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
chr1_-_180641430 | 12.61 |
ENSMUST00000162814.8
|
H3f3a
|
H3.3 histone A |
chr8_-_22675773 | 12.59 |
ENSMUST00000046916.9
|
Ckap2
|
cytoskeleton associated protein 2 |
chr2_+_167922924 | 12.53 |
ENSMUST00000052125.7
|
Pard6b
|
par-6 family cell polarity regulator beta |
chr18_-_46658957 | 12.52 |
ENSMUST00000036226.6
|
Fem1c
|
fem 1 homolog c |
chr18_+_56840813 | 12.47 |
ENSMUST00000025486.9
|
Lmnb1
|
lamin B1 |
chr3_+_30910089 | 12.43 |
ENSMUST00000108261.8
ENSMUST00000108259.8 ENSMUST00000166278.7 ENSMUST00000046748.13 ENSMUST00000194979.6 |
Gpr160
|
G protein-coupled receptor 160 |
chr4_+_101504909 | 12.39 |
ENSMUST00000030254.15
|
Leprot
|
leptin receptor overlapping transcript |
chr14_-_52252003 | 12.39 |
ENSMUST00000226522.2
|
Zfp219
|
zinc finger protein 219 |
chr7_-_28297565 | 12.36 |
ENSMUST00000040531.9
ENSMUST00000108283.8 |
Samd4b
Pak4
|
sterile alpha motif domain containing 4B p21 (RAC1) activated kinase 4 |
chr2_+_156617329 | 12.34 |
ENSMUST00000088552.7
|
Myl9
|
myosin, light polypeptide 9, regulatory |
chr15_+_78810919 | 12.29 |
ENSMUST00000089377.6
|
Lgals1
|
lectin, galactose binding, soluble 1 |
chr4_-_11007635 | 12.26 |
ENSMUST00000054776.4
|
Plekhf2
|
pleckstrin homology domain containing, family F (with FYVE domain) member 2 |
chr8_-_54091980 | 12.25 |
ENSMUST00000047768.11
|
Neil3
|
nei like 3 (E. coli) |
chr10_+_58159288 | 12.25 |
ENSMUST00000020078.14
|
Lims1
|
LIM and senescent cell antigen-like domains 1 |
chr7_-_4167795 | 12.20 |
ENSMUST00000076831.7
|
Cdc42ep5
|
CDC42 effector protein (Rho GTPase binding) 5 |
chr8_-_95602952 | 12.19 |
ENSMUST00000046461.9
|
Dok4
|
docking protein 4 |
chr4_-_41098174 | 12.19 |
ENSMUST00000055327.8
|
Aqp3
|
aquaporin 3 |
chr16_+_76810588 | 12.17 |
ENSMUST00000239066.2
ENSMUST00000023580.8 |
Usp25
|
ubiquitin specific peptidase 25 |
chr11_+_53660834 | 12.14 |
ENSMUST00000108920.10
ENSMUST00000140866.9 ENSMUST00000108922.9 |
Irf1
|
interferon regulatory factor 1 |
chr17_-_57137898 | 12.12 |
ENSMUST00000233000.2
ENSMUST00000002444.15 ENSMUST00000086801.7 |
Rfx2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr5_-_8472582 | 12.05 |
ENSMUST00000168500.8
ENSMUST00000002368.16 |
Dbf4
|
DBF4 zinc finger |
chr7_+_13012735 | 11.98 |
ENSMUST00000098814.13
ENSMUST00000146998.9 |
Lig1
|
ligase I, DNA, ATP-dependent |
chr11_-_69686756 | 11.97 |
ENSMUST00000045971.9
|
Chrnb1
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
chr6_+_49344673 | 11.94 |
ENSMUST00000060561.15
ENSMUST00000121903.2 ENSMUST00000134786.2 |
Fam221a
|
family with sequence similarity 221, member A |
chr1_+_87780985 | 11.93 |
ENSMUST00000027517.14
|
Dgkd
|
diacylglycerol kinase, delta |
chr13_-_100922910 | 11.91 |
ENSMUST00000174038.2
ENSMUST00000091295.14 ENSMUST00000072119.15 |
Ccnb1
|
cyclin B1 |
chr15_-_99773260 | 11.88 |
ENSMUST00000073691.5
|
Lima1
|
LIM domain and actin binding 1 |
chr10_+_78410803 | 11.88 |
ENSMUST00000218763.2
ENSMUST00000220430.2 ENSMUST00000218885.2 ENSMUST00000218215.2 ENSMUST00000218271.2 |
Ilvbl
|
ilvB (bacterial acetolactate synthase)-like |
chrX_+_95139639 | 11.87 |
ENSMUST00000117399.2
|
Msn
|
moesin |
chr5_-_25703700 | 11.81 |
ENSMUST00000173073.8
ENSMUST00000045291.14 ENSMUST00000173174.2 |
Kmt2c
|
lysine (K)-specific methyltransferase 2C |
chr4_+_156046745 | 11.77 |
ENSMUST00000024338.5
|
C1qtnf12
|
C1q and tumor necrosis factor related 12 |
chr15_+_81469538 | 11.73 |
ENSMUST00000068387.11
|
Ep300
|
E1A binding protein p300 |
chr15_-_77726333 | 11.71 |
ENSMUST00000016771.13
|
Myh9
|
myosin, heavy polypeptide 9, non-muscle |
chr16_+_93680783 | 11.65 |
ENSMUST00000023666.11
ENSMUST00000117099.8 |
Chaf1b
|
chromatin assembly factor 1, subunit B (p60) |
chr11_+_117740111 | 11.65 |
ENSMUST00000093906.5
|
Birc5
|
baculoviral IAP repeat-containing 5 |
chr11_+_69826719 | 11.63 |
ENSMUST00000149194.8
|
Ybx2
|
Y box protein 2 |
chr13_+_51325058 | 11.58 |
ENSMUST00000021828.6
|
Nxnl2
|
nucleoredoxin-like 2 |
chr15_+_73384407 | 11.54 |
ENSMUST00000043414.12
|
Dennd3
|
DENN/MADD domain containing 3 |
chr4_+_52439237 | 11.53 |
ENSMUST00000102915.10
ENSMUST00000117280.8 ENSMUST00000142227.3 |
Smc2
|
structural maintenance of chromosomes 2 |
chr9_-_71499628 | 11.53 |
ENSMUST00000093823.8
|
Myzap
|
myocardial zonula adherens protein |
chr1_-_156546600 | 11.49 |
ENSMUST00000122424.8
ENSMUST00000086153.8 |
Fam20b
|
FAM20B, glycosaminoglycan xylosylkinase |
chr18_+_66591604 | 11.47 |
ENSMUST00000025399.9
ENSMUST00000237161.2 ENSMUST00000236933.2 |
Pmaip1
|
phorbol-12-myristate-13-acetate-induced protein 1 |
chr11_-_69838971 | 11.42 |
ENSMUST00000179298.3
ENSMUST00000018710.13 ENSMUST00000135437.3 ENSMUST00000141837.9 ENSMUST00000142500.8 |
Slc2a4
|
solute carrier family 2 (facilitated glucose transporter), member 4 |
chr3_-_94693740 | 11.41 |
ENSMUST00000153263.9
ENSMUST00000107272.7 ENSMUST00000155485.4 |
Cgn
|
cingulin |
chr5_+_97145533 | 11.38 |
ENSMUST00000112974.6
ENSMUST00000035635.10 |
Bmp2k
|
BMP2 inducible kinase |
chr9_-_14663689 | 11.37 |
ENSMUST00000061498.7
|
Fut4
|
fucosyltransferase 4 |
chr4_-_133856025 | 11.33 |
ENSMUST00000105879.2
ENSMUST00000030651.9 |
Sh3bgrl3
|
SH3 domain binding glutamic acid-rich protein-like 3 |
chr15_-_101268036 | 11.32 |
ENSMUST00000077196.6
|
Krt80
|
keratin 80 |
chr4_+_114945905 | 11.30 |
ENSMUST00000171877.8
ENSMUST00000177647.8 ENSMUST00000106548.9 ENSMUST00000030488.3 |
Pdzk1ip1
|
PDZK1 interacting protein 1 |
chr2_+_71617266 | 11.29 |
ENSMUST00000112101.8
ENSMUST00000028522.10 |
Itga6
|
integrin alpha 6 |
chr11_+_121593219 | 11.27 |
ENSMUST00000036742.14
|
Metrnl
|
meteorin, glial cell differentiation regulator-like |
chr2_+_158610003 | 11.27 |
ENSMUST00000029183.3
|
Fam83d
|
family with sequence similarity 83, member D |
chr14_+_20979466 | 11.25 |
ENSMUST00000022369.9
|
Vcl
|
vinculin |
chr5_-_139722046 | 11.23 |
ENSMUST00000044642.14
|
Micall2
|
MICAL-like 2 |
chr5_+_31409021 | 11.22 |
ENSMUST00000054829.13
ENSMUST00000201625.4 ENSMUST00000201937.4 |
Krtcap3
|
keratinocyte associated protein 3 |
chr2_-_26494277 | 11.21 |
ENSMUST00000028286.12
|
Agpat2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) |
chr5_+_145051090 | 11.20 |
ENSMUST00000196111.5
ENSMUST00000141602.2 |
Arpc1b
|
actin related protein 2/3 complex, subunit 1B |
chr7_+_126358771 | 11.20 |
ENSMUST00000050201.11
ENSMUST00000057669.16 |
Mapk3
|
mitogen-activated protein kinase 3 |
chr4_-_43523745 | 11.18 |
ENSMUST00000150592.2
|
Tpm2
|
tropomyosin 2, beta |
chr9_-_45847344 | 11.18 |
ENSMUST00000034590.4
|
Tagln
|
transgelin |
chr7_+_100145192 | 11.15 |
ENSMUST00000133044.3
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr1_+_36510670 | 11.10 |
ENSMUST00000153128.2
|
Cnnm4
|
cyclin M4 |
chr7_-_127593003 | 11.08 |
ENSMUST00000033056.5
|
Pycard
|
PYD and CARD domain containing |
chr3_-_144738526 | 11.08 |
ENSMUST00000029919.7
|
Clca1
|
chloride channel accessory 1 |
chr14_-_20231871 | 11.07 |
ENSMUST00000024011.10
|
Kcnk5
|
potassium channel, subfamily K, member 5 |
chr8_-_11528615 | 11.07 |
ENSMUST00000033900.7
|
Rab20
|
RAB20, member RAS oncogene family |
chr2_+_32766126 | 11.07 |
ENSMUST00000028135.15
|
Niban2
|
niban apoptosis regulator 2 |
chr1_+_90981144 | 11.05 |
ENSMUST00000068167.13
ENSMUST00000097649.10 ENSMUST00000186762.7 ENSMUST00000097650.10 |
Lrrfip1
|
leucine rich repeat (in FLII) interacting protein 1 |
chr14_+_99536111 | 11.05 |
ENSMUST00000005279.8
|
Klf5
|
Kruppel-like factor 5 |
chr8_-_27664651 | 10.97 |
ENSMUST00000054212.7
ENSMUST00000033878.14 ENSMUST00000209377.2 |
Rab11fip1
|
RAB11 family interacting protein 1 (class I) |
chr10_+_79656823 | 10.95 |
ENSMUST00000169041.9
|
Misp
|
mitotic spindle positioning |
chr16_-_45474413 | 10.94 |
ENSMUST00000036732.9
|
BC016579
|
cDNA sequence, BC016579 |
chr1_-_36312482 | 10.94 |
ENSMUST00000056946.8
|
Neurl3
|
neuralized E3 ubiquitin protein ligase 3 |
chr19_-_29302680 | 10.92 |
ENSMUST00000052380.5
|
Insl6
|
insulin-like 6 |
chr10_+_126814542 | 10.91 |
ENSMUST00000105256.10
|
Ctdsp2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
chr14_-_30329765 | 10.85 |
ENSMUST00000112207.8
ENSMUST00000112206.8 ENSMUST00000112202.8 ENSMUST00000112203.2 |
Prkcd
|
protein kinase C, delta |
chr4_+_3938881 | 10.85 |
ENSMUST00000108386.8
ENSMUST00000121110.8 ENSMUST00000149544.8 |
Chchd7
|
coiled-coil-helix-coiled-coil-helix domain containing 7 |
chr2_+_3714492 | 10.82 |
ENSMUST00000027965.11
|
Fam107b
|
family with sequence similarity 107, member B |
chr11_-_69749549 | 10.82 |
ENSMUST00000001626.10
ENSMUST00000108626.8 |
Tnk1
|
tyrosine kinase, non-receptor, 1 |
chr14_-_67953035 | 10.80 |
ENSMUST00000163100.8
ENSMUST00000132705.8 ENSMUST00000124045.3 |
Cdca2
|
cell division cycle associated 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.2 | 45.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
11.5 | 34.5 | GO:1904464 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
10.0 | 10.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
8.7 | 43.5 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
8.5 | 42.7 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
8.2 | 24.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
7.8 | 23.3 | GO:0021682 | nerve maturation(GO:0021682) |
7.7 | 23.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
7.7 | 38.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
7.4 | 22.2 | GO:0034118 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
6.9 | 20.6 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
6.8 | 27.1 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
6.6 | 26.3 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
6.6 | 26.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
6.4 | 38.2 | GO:0002159 | desmosome assembly(GO:0002159) |
6.3 | 25.1 | GO:0032329 | serine transport(GO:0032329) |
6.2 | 37.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
6.1 | 24.6 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
5.9 | 23.5 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
5.8 | 34.9 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
5.8 | 23.3 | GO:0050822 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
5.7 | 17.2 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
5.7 | 45.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
5.7 | 22.7 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
5.6 | 16.9 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
5.6 | 16.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
5.6 | 28.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
5.5 | 5.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
5.5 | 16.5 | GO:0098749 | cerebellar neuron development(GO:0098749) |
5.4 | 16.2 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
5.4 | 5.4 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
5.4 | 16.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
5.3 | 15.9 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
5.3 | 26.4 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
5.2 | 20.9 | GO:1903923 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
5.2 | 15.7 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
5.2 | 5.2 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
5.2 | 15.5 | GO:0045004 | DNA replication proofreading(GO:0045004) |
5.1 | 51.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
5.0 | 5.0 | GO:0010269 | response to selenium ion(GO:0010269) |
5.0 | 20.1 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
5.0 | 20.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
4.9 | 29.6 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
4.9 | 9.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
4.9 | 24.5 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
4.9 | 9.7 | GO:0048627 | myoblast development(GO:0048627) |
4.8 | 14.4 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
4.8 | 38.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
4.7 | 37.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
4.6 | 22.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
4.5 | 4.5 | GO:0006971 | hypotonic response(GO:0006971) |
4.5 | 13.5 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
4.5 | 13.4 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
4.4 | 13.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
4.3 | 17.3 | GO:0015793 | glycerol transport(GO:0015793) |
4.3 | 12.9 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
4.2 | 12.7 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
4.2 | 21.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
4.2 | 12.6 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
4.2 | 4.2 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
4.2 | 20.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
4.2 | 16.6 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
4.1 | 12.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
4.1 | 20.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
4.1 | 12.3 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
4.1 | 12.2 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
4.0 | 8.1 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
4.0 | 11.9 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
3.9 | 7.8 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
3.9 | 19.3 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
3.9 | 19.3 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) negative regulation of regulatory T cell differentiation(GO:0045590) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
3.9 | 42.4 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
3.9 | 11.6 | GO:0014737 | positive regulation of muscle atrophy(GO:0014737) |
3.8 | 11.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
3.8 | 53.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
3.8 | 64.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
3.8 | 7.6 | GO:2001189 | negative regulation of immunological synapse formation(GO:2000521) regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
3.7 | 14.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
3.7 | 14.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
3.7 | 11.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
3.7 | 11.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
3.7 | 11.0 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
3.6 | 10.9 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
3.6 | 39.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
3.6 | 7.1 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
3.5 | 7.1 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
3.5 | 35.4 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
3.5 | 3.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
3.5 | 3.5 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
3.5 | 10.5 | GO:0032218 | riboflavin transport(GO:0032218) |
3.4 | 10.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
3.4 | 13.6 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
3.4 | 6.8 | GO:2000814 | positive regulation of barbed-end actin filament capping(GO:2000814) |
3.4 | 16.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
3.4 | 20.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
3.4 | 10.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
3.4 | 16.8 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
3.3 | 13.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
3.3 | 3.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
3.3 | 9.9 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
3.3 | 9.9 | GO:0046223 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
3.3 | 13.2 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
3.3 | 9.9 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
3.3 | 13.0 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
3.2 | 9.7 | GO:1904826 | regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
3.2 | 6.5 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
3.2 | 12.9 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
3.2 | 32.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
3.2 | 12.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
3.2 | 12.8 | GO:2000880 | dipeptide transmembrane transport(GO:0035442) regulation of oligopeptide transport(GO:0090088) regulation of dipeptide transport(GO:0090089) positive regulation of oligopeptide transport(GO:2000878) positive regulation of dipeptide transport(GO:2000880) regulation of dipeptide transmembrane transport(GO:2001148) positive regulation of dipeptide transmembrane transport(GO:2001150) |
3.2 | 3.2 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) positive regulation of leukocyte tethering or rolling(GO:1903238) |
3.2 | 3.2 | GO:0048536 | spleen development(GO:0048536) |
3.2 | 38.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
3.2 | 12.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
3.2 | 9.5 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
3.1 | 6.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
3.1 | 9.4 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) basophil differentiation(GO:0030221) eosinophil fate commitment(GO:0035854) |
3.1 | 12.5 | GO:0003017 | lymph circulation(GO:0003017) |
3.1 | 3.1 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
3.1 | 12.4 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
3.1 | 9.3 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
3.1 | 6.2 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
3.1 | 21.6 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
3.1 | 9.2 | GO:0061198 | fungiform papilla formation(GO:0061198) |
3.1 | 6.1 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
3.1 | 12.2 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
3.1 | 9.2 | GO:0072347 | response to anesthetic(GO:0072347) |
2.9 | 17.6 | GO:1901563 | response to camptothecin(GO:1901563) |
2.9 | 11.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.9 | 11.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.9 | 11.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.9 | 8.8 | GO:0048320 | axial mesoderm formation(GO:0048320) |
2.9 | 2.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
2.9 | 8.6 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
2.9 | 23.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.8 | 14.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.8 | 42.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.8 | 19.8 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
2.8 | 11.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
2.8 | 30.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
2.8 | 30.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
2.8 | 8.3 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
2.7 | 16.4 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
2.7 | 2.7 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
2.7 | 10.8 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
2.7 | 13.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
2.7 | 21.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
2.7 | 21.5 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
2.7 | 5.3 | GO:0036166 | phenotypic switching(GO:0036166) |
2.7 | 8.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
2.6 | 18.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
2.6 | 60.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
2.6 | 7.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
2.6 | 15.7 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
2.6 | 5.2 | GO:0060003 | copper ion export(GO:0060003) |
2.6 | 5.2 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
2.6 | 20.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.6 | 7.7 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
2.6 | 46.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.6 | 7.7 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
2.6 | 2.6 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
2.5 | 12.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
2.5 | 22.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
2.5 | 10.2 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
2.5 | 2.5 | GO:0070268 | cornification(GO:0070268) |
2.5 | 20.2 | GO:0002432 | granuloma formation(GO:0002432) |
2.5 | 17.6 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
2.5 | 25.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
2.5 | 12.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.5 | 15.0 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
2.5 | 14.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
2.5 | 14.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.5 | 14.8 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
2.5 | 12.4 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
2.5 | 17.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
2.5 | 9.8 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
2.5 | 61.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
2.5 | 19.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
2.5 | 7.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
2.5 | 7.4 | GO:0061193 | taste bud development(GO:0061193) |
2.4 | 22.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
2.4 | 7.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
2.4 | 12.0 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
2.4 | 11.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
2.4 | 23.8 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
2.4 | 11.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.4 | 11.9 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
2.4 | 11.9 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
2.4 | 16.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
2.3 | 7.0 | GO:0097045 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
2.3 | 14.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
2.3 | 62.9 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
2.3 | 2.3 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
2.3 | 9.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
2.3 | 6.9 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
2.3 | 16.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
2.3 | 13.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
2.3 | 6.8 | GO:0010925 | regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010924) positive regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010925) phospholipase C-inhibiting G-protein coupled receptor signaling pathway(GO:0030845) regulation of cell diameter(GO:0060305) |
2.3 | 6.8 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
2.3 | 11.3 | GO:0048382 | mesendoderm development(GO:0048382) |
2.3 | 6.8 | GO:0001762 | beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
2.3 | 4.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
2.3 | 6.8 | GO:0051977 | lysophospholipid transport(GO:0051977) |
2.3 | 38.3 | GO:0043312 | neutrophil degranulation(GO:0043312) |
2.3 | 24.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
2.2 | 20.2 | GO:0044351 | macropinocytosis(GO:0044351) |
2.2 | 15.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
2.2 | 6.7 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
2.2 | 15.6 | GO:0021747 | cochlear nucleus development(GO:0021747) |
2.2 | 19.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.2 | 8.8 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
2.2 | 21.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
2.2 | 17.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
2.2 | 2.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
2.2 | 4.3 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
2.2 | 13.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.2 | 6.5 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
2.1 | 2.1 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
2.1 | 4.3 | GO:0090135 | actin filament branching(GO:0090135) |
2.1 | 2.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
2.1 | 2.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
2.1 | 4.2 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
2.1 | 6.3 | GO:1990428 | miRNA transport(GO:1990428) |
2.1 | 14.6 | GO:0016266 | O-glycan processing(GO:0016266) |
2.1 | 16.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
2.1 | 8.3 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
2.1 | 24.6 | GO:0035878 | nail development(GO:0035878) |
2.1 | 8.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
2.0 | 10.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
2.0 | 10.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.0 | 6.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
2.0 | 12.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
2.0 | 6.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
2.0 | 8.1 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
2.0 | 6.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
2.0 | 2.0 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
2.0 | 20.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
2.0 | 4.0 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
2.0 | 6.0 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
2.0 | 2.0 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
2.0 | 8.0 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
2.0 | 22.0 | GO:0007525 | somatic muscle development(GO:0007525) |
2.0 | 29.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
2.0 | 2.0 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
2.0 | 5.9 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
2.0 | 21.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.0 | 5.9 | GO:0046967 | cytosol to ER transport(GO:0046967) |
2.0 | 15.7 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.9 | 13.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.9 | 3.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.9 | 25.0 | GO:0001842 | neural fold formation(GO:0001842) |
1.9 | 11.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.9 | 7.7 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
1.9 | 3.8 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
1.9 | 9.5 | GO:0003383 | apical constriction(GO:0003383) |
1.9 | 7.6 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
1.9 | 15.2 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
1.9 | 11.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.9 | 1.9 | GO:2000422 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
1.9 | 54.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
1.9 | 15.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
1.9 | 5.6 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.9 | 5.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
1.9 | 1.9 | GO:0002934 | desmosome organization(GO:0002934) |
1.9 | 7.4 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
1.9 | 3.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
1.8 | 20.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
1.8 | 1.8 | GO:1904444 | regulation of establishment of Sertoli cell barrier(GO:1904444) |
1.8 | 9.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.8 | 22.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.8 | 7.3 | GO:0043096 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.8 | 12.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.8 | 21.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.8 | 10.8 | GO:1904177 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
1.8 | 5.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.8 | 3.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.8 | 7.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.8 | 16.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.8 | 9.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.8 | 35.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.8 | 1.8 | GO:0070671 | response to interleukin-12(GO:0070671) |
1.8 | 5.4 | GO:0071336 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
1.8 | 5.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.8 | 1.8 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
1.8 | 10.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.8 | 5.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.8 | 7.0 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
1.8 | 5.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.8 | 1.8 | GO:0046078 | dUMP metabolic process(GO:0046078) |
1.7 | 12.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.7 | 10.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
1.7 | 3.5 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
1.7 | 8.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.7 | 5.2 | GO:0097184 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
1.7 | 10.4 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
1.7 | 3.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.7 | 3.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.7 | 13.8 | GO:0007144 | female meiosis I(GO:0007144) |
1.7 | 3.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.7 | 12.0 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
1.7 | 10.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.7 | 27.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
1.7 | 1.7 | GO:0031296 | B cell costimulation(GO:0031296) |
1.7 | 37.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
1.7 | 3.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.7 | 5.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
1.7 | 3.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.7 | 8.4 | GO:0030576 | Cajal body organization(GO:0030576) |
1.7 | 11.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.7 | 16.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.7 | 6.7 | GO:1902045 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
1.7 | 8.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.6 | 4.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.6 | 8.2 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
1.6 | 14.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
1.6 | 4.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.6 | 4.9 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
1.6 | 8.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
1.6 | 8.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.6 | 50.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
1.6 | 13.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.6 | 4.9 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.6 | 6.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.6 | 6.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
1.6 | 4.8 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
1.6 | 6.4 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
1.6 | 11.2 | GO:0015705 | iodide transport(GO:0015705) |
1.6 | 11.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.6 | 9.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
1.6 | 17.4 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
1.6 | 4.7 | GO:0036245 | cellular response to menadione(GO:0036245) |
1.6 | 7.8 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.6 | 3.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.6 | 1.6 | GO:0001832 | blastocyst growth(GO:0001832) inner cell mass cell proliferation(GO:0001833) |
1.6 | 9.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.6 | 3.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
1.6 | 6.2 | GO:0036337 | Fas signaling pathway(GO:0036337) |
1.6 | 10.9 | GO:1903232 | melanosome assembly(GO:1903232) |
1.6 | 12.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
1.6 | 6.2 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
1.5 | 47.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.5 | 12.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.5 | 9.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.5 | 1.5 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of myofibroblast differentiation(GO:1904761) |
1.5 | 25.8 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.5 | 10.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.5 | 15.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.5 | 6.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.5 | 6.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.5 | 4.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.5 | 9.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
1.5 | 4.5 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
1.5 | 4.5 | GO:0044838 | cell quiescence(GO:0044838) |
1.5 | 3.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
1.5 | 4.5 | GO:0000301 | protein targeting to Golgi(GO:0000042) retrograde transport, vesicle recycling within Golgi(GO:0000301) |
1.5 | 4.5 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
1.5 | 20.8 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
1.5 | 16.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.5 | 16.3 | GO:0070986 | left/right axis specification(GO:0070986) |
1.5 | 14.8 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
1.5 | 7.4 | GO:0006972 | hyperosmotic response(GO:0006972) |
1.5 | 14.8 | GO:0070836 | caveola assembly(GO:0070836) |
1.5 | 4.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.5 | 13.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.5 | 8.8 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
1.5 | 1.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.5 | 11.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.5 | 36.6 | GO:0048255 | mRNA stabilization(GO:0048255) |
1.5 | 10.2 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
1.5 | 1.5 | GO:0030091 | protein repair(GO:0030091) |
1.4 | 1.4 | GO:0097494 | regulation of vesicle size(GO:0097494) |
1.4 | 4.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
1.4 | 1.4 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
1.4 | 2.9 | GO:0009644 | response to high light intensity(GO:0009644) |
1.4 | 5.7 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
1.4 | 5.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.4 | 18.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
1.4 | 8.5 | GO:0015871 | choline transport(GO:0015871) |
1.4 | 8.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.4 | 9.9 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
1.4 | 4.3 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.4 | 5.7 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) |
1.4 | 4.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
1.4 | 7.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
1.4 | 8.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
1.4 | 1.4 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
1.4 | 8.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.4 | 12.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.4 | 4.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.4 | 18.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.4 | 32.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
1.4 | 5.6 | GO:0061296 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
1.4 | 8.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
1.4 | 4.2 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
1.4 | 2.8 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.4 | 2.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
1.4 | 15.2 | GO:0060056 | mammary gland involution(GO:0060056) |
1.4 | 16.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.4 | 8.3 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.4 | 4.1 | GO:1904172 | positive regulation of bleb assembly(GO:1904172) |
1.4 | 4.1 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
1.4 | 9.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.4 | 4.1 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
1.4 | 38.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
1.4 | 4.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
1.4 | 21.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.4 | 4.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.4 | 2.7 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.3 | 9.4 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.3 | 6.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.3 | 10.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.3 | 91.2 | GO:0043297 | apical junction assembly(GO:0043297) |
1.3 | 14.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.3 | 4.0 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
1.3 | 5.3 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
1.3 | 4.0 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
1.3 | 1.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.3 | 7.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.3 | 21.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
1.3 | 5.3 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.3 | 2.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
1.3 | 3.9 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.3 | 5.2 | GO:0009597 | detection of virus(GO:0009597) |
1.3 | 18.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.3 | 2.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.3 | 6.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.3 | 1.3 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.3 | 5.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.3 | 1.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.3 | 2.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.3 | 32.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.3 | 2.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.3 | 8.8 | GO:0008354 | germ cell migration(GO:0008354) |
1.3 | 2.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
1.3 | 8.8 | GO:0051697 | protein delipidation(GO:0051697) |
1.3 | 5.0 | GO:0042335 | cuticle development(GO:0042335) |
1.2 | 7.5 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
1.2 | 2.5 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
1.2 | 18.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.2 | 5.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
1.2 | 2.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.2 | 16.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.2 | 5.0 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
1.2 | 31.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.2 | 2.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.2 | 2.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.2 | 34.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.2 | 1.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
1.2 | 4.9 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
1.2 | 2.4 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.2 | 1.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.2 | 14.6 | GO:0051451 | myoblast migration(GO:0051451) |
1.2 | 4.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.2 | 6.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.2 | 32.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.2 | 8.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
1.2 | 12.1 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
1.2 | 2.4 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
1.2 | 4.8 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
1.2 | 8.4 | GO:0097503 | sialylation(GO:0097503) |
1.2 | 38.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.2 | 3.6 | GO:0007315 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
1.2 | 1.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
1.2 | 6.0 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
1.2 | 4.8 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
1.2 | 4.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.2 | 10.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
1.2 | 5.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.2 | 11.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.2 | 10.7 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
1.2 | 3.5 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
1.2 | 7.0 | GO:0019659 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.2 | 3.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.2 | 1.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.2 | 5.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.2 | 32.5 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
1.2 | 2.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
1.2 | 9.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.2 | 3.5 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
1.2 | 3.5 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
1.2 | 5.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.2 | 4.6 | GO:0015811 | L-cystine transport(GO:0015811) |
1.1 | 9.2 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.1 | 1.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.1 | 3.4 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
1.1 | 1.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.1 | 3.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
1.1 | 20.5 | GO:0001675 | acrosome assembly(GO:0001675) |
1.1 | 4.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.1 | 6.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.1 | 10.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
1.1 | 1.1 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
1.1 | 3.4 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.1 | 6.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.1 | 19.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
1.1 | 7.8 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
1.1 | 1.1 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
1.1 | 3.3 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
1.1 | 4.4 | GO:0097298 | regulation of nucleus size(GO:0097298) |
1.1 | 5.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.1 | 12.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.1 | 9.9 | GO:0007379 | segment specification(GO:0007379) |
1.1 | 5.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.1 | 5.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
1.1 | 2.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.1 | 4.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.1 | 5.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
1.1 | 21.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
1.1 | 1.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.1 | 15.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.1 | 19.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.1 | 20.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.1 | 3.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
1.1 | 4.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.1 | 4.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.1 | 8.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.1 | 1.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.1 | 5.4 | GO:0070672 | interleukin-15-mediated signaling pathway(GO:0035723) response to interleukin-15(GO:0070672) cellular response to interleukin-15(GO:0071350) |
1.1 | 4.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.1 | 2.1 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
1.1 | 2.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.1 | 3.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.1 | 5.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.1 | 4.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.1 | 12.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.1 | 4.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
1.1 | 19.0 | GO:0031100 | organ regeneration(GO:0031100) |
1.1 | 12.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.1 | 1.1 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
1.0 | 2.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.0 | 4.2 | GO:0018377 | protein myristoylation(GO:0018377) |
1.0 | 18.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.0 | 3.1 | GO:0072278 | metanephric comma-shaped body morphogenesis(GO:0072278) |
1.0 | 4.2 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
1.0 | 2.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.0 | 3.1 | GO:0055130 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
1.0 | 2.1 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
1.0 | 1.0 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
1.0 | 3.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.0 | 10.4 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
1.0 | 6.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
1.0 | 16.5 | GO:0032060 | bleb assembly(GO:0032060) |
1.0 | 6.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
1.0 | 4.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.0 | 6.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
1.0 | 2.1 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
1.0 | 3.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.0 | 7.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.0 | 7.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
1.0 | 1.0 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.0 | 2.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.0 | 5.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.0 | 3.0 | GO:0015881 | creatine transport(GO:0015881) |
1.0 | 7.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
1.0 | 11.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.0 | 6.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.0 | 72.9 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
1.0 | 22.9 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
1.0 | 4.0 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.0 | 7.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.0 | 4.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.0 | 14.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.0 | 2.0 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.0 | 3.9 | GO:0030202 | heparin metabolic process(GO:0030202) |
1.0 | 3.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.0 | 6.9 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
1.0 | 2.9 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.0 | 5.9 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.0 | 1.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.0 | 5.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
1.0 | 2.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.0 | 4.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.0 | 3.9 | GO:0071321 | cellular response to cGMP(GO:0071321) |
1.0 | 7.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
1.0 | 1.9 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) |
1.0 | 1.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.0 | 4.8 | GO:0033504 | floor plate development(GO:0033504) |
1.0 | 2.9 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
1.0 | 1.9 | GO:0060037 | pharyngeal system development(GO:0060037) |
1.0 | 7.7 | GO:0014842 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
1.0 | 4.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
1.0 | 1.0 | GO:0019046 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
1.0 | 7.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) negative regulation of podosome assembly(GO:0071802) |
1.0 | 1.9 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
1.0 | 1.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.0 | 11.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.0 | 8.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.9 | 0.9 | GO:0001878 | response to yeast(GO:0001878) |
0.9 | 14.2 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.9 | 16.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.9 | 18.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.9 | 12.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.9 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 3.8 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.9 | 8.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.9 | 1.9 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.9 | 9.4 | GO:0015879 | carnitine transport(GO:0015879) |
0.9 | 7.5 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.9 | 15.9 | GO:0001562 | response to protozoan(GO:0001562) |
0.9 | 14.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.9 | 6.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.9 | 5.6 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.9 | 2.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.9 | 3.7 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.9 | 5.6 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 1.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.9 | 3.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.9 | 13.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.9 | 3.7 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.9 | 3.7 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) |
0.9 | 4.6 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.9 | 1.8 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.9 | 4.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.9 | 11.0 | GO:0070633 | transepithelial transport(GO:0070633) |
0.9 | 4.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.9 | 10.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.9 | 3.7 | GO:1902477 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.9 | 2.7 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.9 | 2.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.9 | 2.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.9 | 0.9 | GO:0009750 | response to fructose(GO:0009750) |
0.9 | 13.6 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.9 | 5.4 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.9 | 7.2 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.9 | 4.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.9 | 5.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.9 | 5.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.9 | 1.8 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.9 | 21.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.9 | 2.7 | GO:0016240 | autophagosome docking(GO:0016240) |
0.9 | 2.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.9 | 3.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.9 | 0.9 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.9 | 4.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.9 | 2.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.9 | 4.4 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.9 | 1.8 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.9 | 7.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.9 | 20.3 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.9 | 4.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.9 | 1.8 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.9 | 2.6 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.9 | 7.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.9 | 5.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.9 | 1.7 | GO:0002215 | defense response to nematode(GO:0002215) |
0.9 | 19.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.9 | 4.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.9 | 2.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.9 | 1.7 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.9 | 0.9 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.9 | 10.3 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.9 | 6.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.9 | 10.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.9 | 2.6 | GO:0042637 | catagen(GO:0042637) |
0.9 | 2.6 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.9 | 2.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.8 | 1.7 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.8 | 1.7 | GO:0010224 | response to UV-B(GO:0010224) |
0.8 | 1.7 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.8 | 3.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.8 | 5.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.8 | 1.7 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
0.8 | 4.2 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.8 | 5.8 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.8 | 4.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.8 | 4.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.8 | 2.5 | GO:0042938 | dipeptide transport(GO:0042938) |
0.8 | 4.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.8 | 3.3 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.8 | 4.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.8 | 1.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.8 | 6.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.8 | 18.8 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.8 | 0.8 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.8 | 3.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.8 | 5.7 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.8 | 10.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.8 | 7.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.8 | 4.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.8 | 4.0 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.8 | 0.8 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.8 | 3.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.8 | 3.2 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.8 | 1.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.8 | 14.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.8 | 4.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.8 | 6.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.8 | 38.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.8 | 3.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.8 | 5.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.8 | 7.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.8 | 2.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.8 | 4.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.8 | 0.8 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.8 | 2.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.8 | 12.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.8 | 3.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.8 | 10.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.8 | 0.8 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.8 | 1.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.8 | 6.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.8 | 3.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.8 | 5.4 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.8 | 12.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.8 | 4.6 | GO:0032506 | cytokinetic process(GO:0032506) |
0.8 | 2.3 | GO:0071846 | actin filament debranching(GO:0071846) |
0.8 | 0.8 | GO:2000011 | adaxial/abaxial pattern specification(GO:0009955) regulation of adaxial/abaxial pattern formation(GO:2000011) |
0.8 | 0.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.8 | 11.4 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.8 | 12.9 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.8 | 2.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.8 | 6.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 3.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.8 | 6.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.8 | 3.0 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.8 | 21.1 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.8 | 2.3 | GO:0007225 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.7 | 2.2 | GO:0030952 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.7 | 2.2 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.7 | 3.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.7 | 3.0 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.7 | 4.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.7 | 1.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.7 | 9.6 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.7 | 3.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.7 | 11.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.7 | 13.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.7 | 6.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.7 | 0.7 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.7 | 11.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.7 | 0.7 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.7 | 0.7 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.7 | 2.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.7 | 3.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.7 | 6.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 0.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.7 | 6.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.7 | 7.9 | GO:2001199 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.7 | 4.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.7 | 8.6 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.7 | 2.9 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.7 | 2.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.7 | 2.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.7 | 3.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.7 | 3.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.7 | 2.8 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.7 | 4.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.7 | 4.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 1.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.7 | 10.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.7 | 17.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.7 | 11.3 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.7 | 2.8 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) |
0.7 | 2.8 | GO:0051572 | negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) |
0.7 | 1.4 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.7 | 4.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.7 | 14.6 | GO:0009299 | mRNA transcription(GO:0009299) |
0.7 | 2.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.7 | 13.9 | GO:0001706 | endoderm formation(GO:0001706) |
0.7 | 1.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 0.7 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) trigeminal ganglion development(GO:0061551) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) facioacoustic ganglion development(GO:1903375) |
0.7 | 3.5 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.7 | 1.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.7 | 2.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.7 | 0.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.7 | 3.4 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.7 | 6.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.7 | 3.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 3.4 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.7 | 2.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.7 | 2.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.7 | 9.6 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.7 | 22.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.7 | 10.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.7 | 0.7 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.7 | 13.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.7 | 0.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.7 | 2.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.7 | 1.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.7 | 6.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.7 | 0.7 | GO:1903699 | tarsal gland development(GO:1903699) |
0.7 | 6.7 | GO:0051026 | chiasma assembly(GO:0051026) |
0.7 | 6.0 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.7 | 2.7 | GO:0043584 | nose development(GO:0043584) |
0.7 | 2.0 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.7 | 26.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.7 | 2.0 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.7 | 12.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.7 | 0.7 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.7 | 0.7 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.7 | 16.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.7 | 2.6 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.7 | 2.0 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.7 | 2.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.7 | 4.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.7 | 9.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.7 | 22.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.7 | 5.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.7 | 1.3 | GO:0071640 | regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
0.7 | 6.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.7 | 8.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.7 | 3.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.7 | 9.8 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.6 | 5.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.6 | 2.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.6 | 2.6 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.6 | 3.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.6 | 1.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.6 | 0.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.6 | 6.4 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.6 | 7.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.6 | 11.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.6 | 5.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 1.9 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.6 | 5.7 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.6 | 1.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.6 | 29.1 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.6 | 1.3 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.6 | 1.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.6 | 6.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.6 | 2.5 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.6 | 5.0 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.6 | 7.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.6 | 1.2 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.6 | 3.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.6 | 6.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.6 | 3.1 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.6 | 4.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.6 | 9.2 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.6 | 10.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 3.0 | GO:0060324 | face development(GO:0060324) |
0.6 | 12.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.6 | 3.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.6 | 3.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.6 | 1.8 | GO:0060022 | hard palate development(GO:0060022) |
0.6 | 2.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.6 | 1.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.6 | 6.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 4.8 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.6 | 6.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.6 | 7.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.6 | 17.7 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.6 | 4.1 | GO:0030325 | adrenal gland development(GO:0030325) |
0.6 | 4.1 | GO:0007143 | female meiotic division(GO:0007143) |
0.6 | 4.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.6 | 0.6 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.6 | 4.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 4.7 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.6 | 11.6 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.6 | 0.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.6 | 2.9 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.6 | 3.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.6 | 1.7 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.6 | 3.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.6 | 1.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.6 | 1.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.6 | 4.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.6 | 5.7 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.6 | 3.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 0.6 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.6 | 2.8 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.6 | 4.0 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.6 | 7.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.6 | 6.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.6 | 5.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.6 | 6.2 | GO:0015074 | DNA integration(GO:0015074) |
0.6 | 11.8 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.6 | 2.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.6 | 5.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.6 | 1.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.5 | 2.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.5 | 2.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 6.0 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.5 | 2.2 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
0.5 | 0.5 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.5 | 2.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.5 | 2.7 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.5 | 2.7 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.5 | 3.8 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.5 | 2.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.5 | 5.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.5 | 18.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 2.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.5 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.5 | 2.6 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.5 | 3.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 0.5 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.5 | 4.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.5 | 3.7 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.5 | 1.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 4.1 | GO:0048538 | thymus development(GO:0048538) |
0.5 | 9.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 1.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
0.5 | 6.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 5.1 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.5 | 1.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 2.6 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.5 | 2.6 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.5 | 4.6 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.5 | 1.5 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.5 | 1.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.5 | 2.0 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.5 | 6.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 2.5 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.5 | 3.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.5 | 2.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.5 | 2.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.5 | 10.5 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.5 | 25.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.5 | 8.9 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.5 | 2.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 2.0 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.5 | 2.0 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.5 | 3.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.5 | 1.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.5 | 2.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 6.3 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.5 | 2.4 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.5 | 2.9 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.5 | 5.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.5 | 1.0 | GO:0070839 | divalent metal ion export(GO:0070839) |
0.5 | 1.4 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
0.5 | 7.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.5 | 4.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 0.5 | GO:0009838 | abscission(GO:0009838) |
0.5 | 3.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.5 | 16.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.5 | 2.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.5 | 1.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.5 | 1.4 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.5 | 3.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 5.7 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.5 | 2.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.5 | 0.9 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.5 | 1.4 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.5 | 0.5 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.5 | 1.8 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.5 | 3.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 3.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.5 | 2.3 | GO:1900150 | antifungal innate immune response(GO:0061760) regulation of defense response to fungus(GO:1900150) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.5 | 0.9 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 1.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 0.5 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.5 | 4.5 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.5 | 0.5 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.5 | 0.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.5 | 6.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 4.5 | GO:0030850 | prostate gland development(GO:0030850) |
0.5 | 3.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.5 | 0.9 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.5 | 0.9 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.5 | 2.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.4 | 3.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 1.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 1.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.4 | 2.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.4 | 0.9 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.4 | 0.9 | GO:0021764 | amygdala development(GO:0021764) |
0.4 | 0.9 | GO:0061056 | sclerotome development(GO:0061056) |
0.4 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 0.4 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.4 | 0.9 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.4 | 0.9 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.4 | 7.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 6.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 0.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.4 | 14.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 2.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.4 | 0.9 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 6.9 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.4 | 0.9 | GO:1905214 | histone H3-R17 methylation(GO:0034971) regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.4 | 3.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.4 | 3.4 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.4 | 0.4 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.4 | 2.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.4 | 1.3 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.4 | 5.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.4 | 1.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.4 | 4.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.4 | 1.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.4 | 3.4 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 1.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 0.8 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.4 | 0.8 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.4 | 1.7 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.4 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 1.2 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.4 | 2.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 1.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 1.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 1.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.4 | 7.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.4 | 1.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.4 | 0.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.4 | 1.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 1.6 | GO:0002353 | plasma kallikrein-kinin cascade(GO:0002353) |
0.4 | 4.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 0.8 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.4 | 0.4 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.4 | 2.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 0.8 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.4 | 1.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.4 | 1.2 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.4 | 4.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 9.9 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.4 | 6.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.4 | 4.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.4 | 1.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.4 | 2.0 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.4 | 2.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 6.7 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.4 | 4.7 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.4 | 2.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.4 | 1.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.4 | 2.7 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 12.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.4 | 5.8 | GO:0002076 | osteoblast development(GO:0002076) |
0.4 | 1.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 3.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.4 | 0.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 1.9 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.4 | 11.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 0.4 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.4 | 1.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 13.0 | GO:0016925 | protein sumoylation(GO:0016925) |
0.4 | 5.9 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.4 | 1.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.4 | 5.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 8.5 | GO:0031424 | keratinization(GO:0031424) |
0.4 | 8.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.4 | 9.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.4 | 6.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.4 | 1.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.4 | 6.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 1.8 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.4 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 3.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.4 | 1.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.4 | 1.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.4 | 1.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.4 | 10.3 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.4 | 0.7 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.4 | 2.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 1.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 2.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.4 | 1.8 | GO:2000698 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.4 | 0.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.4 | 6.7 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.4 | 15.1 | GO:1901998 | toxin transport(GO:1901998) |
0.4 | 1.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.4 | 9.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.4 | 1.8 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.4 | 2.8 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.3 | 2.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 1.7 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) positive regulation of T cell tolerance induction(GO:0002666) |
0.3 | 1.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 4.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.3 | 0.3 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 0.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 3.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 11.0 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.3 | 1.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 1.0 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 1.7 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.3 | 1.0 | GO:0072355 | histone H3-T3 phosphorylation(GO:0072355) |
0.3 | 1.0 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.3 | 1.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 2.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.3 | 2.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.3 | 2.7 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.3 | 1.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 11.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.3 | 1.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 0.3 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.3 | 1.6 | GO:0035660 | MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
0.3 | 2.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 1.9 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 2.9 | GO:0031050 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.3 | 1.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 2.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 2.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 1.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 2.9 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 1.0 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle morphogenesis(GO:0071600) |
0.3 | 1.9 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.3 | 3.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 1.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.3 | 3.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 0.6 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.3 | 0.9 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 4.9 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.3 | 2.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 12.4 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.3 | 6.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.3 | 1.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.9 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.3 | 1.8 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 12.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 0.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.3 | 23.3 | GO:0030217 | T cell differentiation(GO:0030217) |
0.3 | 11.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.3 | 2.9 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.3 | 6.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 6.7 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.3 | 1.2 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.3 | 0.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 51.0 | GO:0009615 | response to virus(GO:0009615) |
0.3 | 4.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 1.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 2.6 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.3 | 3.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 1.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 1.4 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.3 | 0.6 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.3 | 1.7 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.3 | 1.4 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.3 | 15.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 1.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.3 | 4.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 0.8 | GO:1990839 | response to endothelin(GO:1990839) |
0.3 | 1.1 | GO:0010286 | heat acclimation(GO:0010286) |
0.3 | 1.4 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.3 | 9.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 2.2 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.3 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 14.1 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.3 | 12.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.3 | 0.5 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 0.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 1.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 0.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 12.3 | GO:0030317 | sperm motility(GO:0030317) |
0.3 | 7.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 3.9 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.3 | 0.5 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.3 | 0.5 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 1.0 | GO:0097475 | motor neuron migration(GO:0097475) |
0.3 | 2.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.3 | 0.8 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 3.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 4.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 13.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 1.5 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.2 | 1.0 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 1.0 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 1.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.4 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.9 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.2 | 3.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 4.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 1.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 7.5 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 0.5 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 1.1 | GO:0060356 | leucine import(GO:0060356) |
0.2 | 0.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 2.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.9 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 1.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 0.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 3.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.2 | 1.1 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 1.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.2 | 0.6 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.2 | 1.3 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.2 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.2 | GO:0071469 | response to alkaline pH(GO:0010446) cellular response to alkaline pH(GO:0071469) |
0.2 | 0.4 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.8 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.2 | 2.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.2 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 1.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 1.7 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 3.5 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.2 | 1.9 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 1.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 2.9 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.2 | 2.7 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 1.6 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.6 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 2.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.6 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 0.2 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
0.2 | 1.0 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.2 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 2.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 9.9 | GO:0038127 | ERBB signaling pathway(GO:0038127) |
0.2 | 1.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 1.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 26.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 4.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.2 | 0.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.4 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.2 | 2.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 1.3 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.2 | 2.1 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.2 | 0.6 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.2 | 3.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 0.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 2.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 5.2 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.7 | GO:0032392 | DNA geometric change(GO:0032392) |
0.2 | 0.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.7 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 0.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 3.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 11.7 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.3 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.2 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.2 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 23.1 | GO:0010324 | membrane invagination(GO:0010324) |
0.2 | 2.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 1.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 1.0 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 0.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.6 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) |
0.2 | 0.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.3 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.2 | 0.9 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 0.2 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 1.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.9 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 0.6 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.2 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.9 | GO:0017145 | stem cell division(GO:0017145) |
0.2 | 0.5 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.2 | 1.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 1.2 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.3 | GO:0032924 | activin receptor signaling pathway(GO:0032924) regulation of activin receptor signaling pathway(GO:0032925) |
0.1 | 0.6 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.9 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.1 | 4.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 2.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 11.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 1.0 | GO:0051292 | pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
0.1 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.1 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 0.7 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.8 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.4 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 1.1 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 6.7 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.1 | 0.9 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.4 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 0.9 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 1.8 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 1.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 1.4 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 2.6 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.4 | GO:0042694 | muscle cell fate specification(GO:0042694) |
0.1 | 0.6 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.1 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.2 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.5 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 11.5 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 2.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.6 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.4 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.1 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
0.1 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 2.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.2 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 1.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.3 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 1.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 1.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.1 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 1.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 2.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.8 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 1.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 3.2 | GO:0048747 | muscle fiber development(GO:0048747) |
0.1 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 1.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 1.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.6 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 1.2 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 2.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.9 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 4.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:1903371 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.2 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 2.2 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.1 | 0.4 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 1.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.7 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.5 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.4 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 1.0 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.5 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.0 | 0.2 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.2 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0072393 | microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.0 | 0.4 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.0 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.0 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.0 | 0.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.7 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.0 | 48.0 | GO:0001740 | Barr body(GO:0001740) |
10.2 | 30.7 | GO:0097224 | sperm connecting piece(GO:0097224) |
8.9 | 53.4 | GO:0031523 | Myb complex(GO:0031523) |
8.8 | 26.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
6.8 | 27.4 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
6.4 | 19.2 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
5.7 | 28.4 | GO:0005914 | spot adherens junction(GO:0005914) |
5.4 | 65.1 | GO:0000796 | condensin complex(GO:0000796) |
5.2 | 20.8 | GO:0036284 | tubulobulbar complex(GO:0036284) |
5.0 | 19.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
4.9 | 14.7 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
4.8 | 85.6 | GO:0090543 | Flemming body(GO:0090543) |
4.7 | 14.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
4.1 | 12.2 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
4.0 | 20.2 | GO:0043293 | apoptosome(GO:0043293) |
4.0 | 20.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
3.8 | 56.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
3.8 | 3.8 | GO:0043219 | lateral loop(GO:0043219) |
3.8 | 18.8 | GO:0045160 | myosin I complex(GO:0045160) |
3.7 | 29.7 | GO:0042825 | TAP complex(GO:0042825) |
3.7 | 14.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
3.7 | 47.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
3.7 | 76.9 | GO:0031143 | pseudopodium(GO:0031143) |
3.6 | 3.6 | GO:0071564 | npBAF complex(GO:0071564) |
3.4 | 6.8 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
3.3 | 13.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
3.3 | 29.3 | GO:1990357 | terminal web(GO:1990357) |
3.2 | 15.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
3.1 | 86.5 | GO:0070938 | contractile ring(GO:0070938) |
3.1 | 12.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.9 | 14.7 | GO:0071953 | elastic fiber(GO:0071953) |
2.9 | 14.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.9 | 20.2 | GO:0005638 | lamin filament(GO:0005638) |
2.9 | 5.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.9 | 5.7 | GO:0097342 | ripoptosome(GO:0097342) |
2.8 | 31.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
2.8 | 14.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
2.8 | 30.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
2.8 | 11.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.8 | 5.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
2.8 | 44.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.7 | 16.4 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
2.7 | 24.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
2.6 | 5.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
2.6 | 13.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.6 | 20.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
2.6 | 10.3 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
2.6 | 2.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.5 | 60.9 | GO:0042581 | specific granule(GO:0042581) |
2.5 | 9.9 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
2.4 | 26.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
2.3 | 7.0 | GO:0045298 | tubulin complex(GO:0045298) |
2.3 | 4.6 | GO:0016342 | catenin complex(GO:0016342) |
2.2 | 13.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.2 | 6.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.2 | 6.5 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
2.1 | 6.4 | GO:0031904 | endosome lumen(GO:0031904) |
2.1 | 6.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
2.1 | 8.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.1 | 6.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
2.1 | 25.2 | GO:0008278 | cohesin complex(GO:0008278) |
2.1 | 21.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
2.1 | 24.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.0 | 34.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
2.0 | 97.8 | GO:0002102 | podosome(GO:0002102) |
2.0 | 5.9 | GO:0032783 | ELL-EAF complex(GO:0032783) |
2.0 | 17.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.0 | 3.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
2.0 | 23.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.9 | 17.4 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.9 | 21.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.9 | 20.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.9 | 13.2 | GO:1990246 | uniplex complex(GO:1990246) |
1.9 | 11.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.9 | 5.6 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
1.9 | 14.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.8 | 11.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.8 | 23.9 | GO:0097427 | microtubule bundle(GO:0097427) |
1.8 | 21.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.8 | 12.5 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.8 | 33.8 | GO:0016580 | Sin3 complex(GO:0016580) |
1.8 | 14.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.7 | 24.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.7 | 16.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.7 | 16.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.7 | 29.8 | GO:0016600 | flotillin complex(GO:0016600) |
1.6 | 25.9 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
1.6 | 32.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.6 | 11.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.6 | 14.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.6 | 11.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
1.6 | 9.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.6 | 7.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.6 | 10.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.6 | 56.2 | GO:0042588 | zymogen granule(GO:0042588) |
1.6 | 17.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.5 | 16.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.5 | 7.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.5 | 18.1 | GO:0005915 | zonula adherens(GO:0005915) |
1.5 | 12.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.5 | 4.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
1.5 | 17.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.5 | 11.8 | GO:0097422 | tubular endosome(GO:0097422) |
1.4 | 4.3 | GO:0042585 | germinal vesicle(GO:0042585) |
1.4 | 4.3 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
1.4 | 7.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.4 | 7.1 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
1.4 | 2.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.4 | 41.3 | GO:0030057 | desmosome(GO:0030057) |
1.4 | 4.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.4 | 49.0 | GO:0008305 | integrin complex(GO:0008305) |
1.4 | 8.2 | GO:0016589 | NURF complex(GO:0016589) |
1.3 | 13.3 | GO:0001940 | male pronucleus(GO:0001940) |
1.3 | 6.5 | GO:0070449 | elongin complex(GO:0070449) |
1.3 | 31.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.3 | 3.9 | GO:0000811 | GINS complex(GO:0000811) |
1.3 | 10.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.3 | 9.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.3 | 16.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.3 | 5.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.3 | 38.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.2 | 4.9 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
1.2 | 14.6 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
1.2 | 8.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.2 | 151.9 | GO:0032432 | actin filament bundle(GO:0032432) |
1.2 | 3.6 | GO:0001652 | granular component(GO:0001652) |
1.2 | 6.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.2 | 3.6 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
1.2 | 8.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.2 | 20.8 | GO:0005605 | basal lamina(GO:0005605) |
1.1 | 17.2 | GO:0042555 | MCM complex(GO:0042555) |
1.1 | 8.0 | GO:0036396 | MIS complex(GO:0036396) |
1.1 | 4.6 | GO:0035061 | interchromatin granule(GO:0035061) |
1.1 | 5.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.1 | 4.6 | GO:0031417 | NatC complex(GO:0031417) |
1.1 | 47.8 | GO:0045095 | keratin filament(GO:0045095) |
1.1 | 14.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.1 | 3.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
1.1 | 7.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.1 | 31.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.1 | 12.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.1 | 16.6 | GO:0097470 | ribbon synapse(GO:0097470) |
1.1 | 9.9 | GO:0070652 | HAUS complex(GO:0070652) |
1.1 | 16.4 | GO:0032433 | filopodium tip(GO:0032433) |
1.1 | 28.3 | GO:0032426 | stereocilium tip(GO:0032426) |
1.1 | 86.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.1 | 3.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.1 | 4.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.1 | 4.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
1.1 | 6.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.1 | 65.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.1 | 10.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.0 | 49.4 | GO:0032420 | stereocilium(GO:0032420) |
1.0 | 7.1 | GO:0070695 | FHF complex(GO:0070695) |
1.0 | 7.1 | GO:0072487 | MSL complex(GO:0072487) |
1.0 | 2.0 | GO:0044393 | microspike(GO:0044393) |
1.0 | 190.6 | GO:0043296 | apical junction complex(GO:0043296) |
1.0 | 4.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
1.0 | 2.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.0 | 4.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
1.0 | 4.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.0 | 6.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.0 | 5.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.0 | 38.2 | GO:0005876 | spindle microtubule(GO:0005876) |
1.0 | 2.9 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.9 | 78.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.9 | 3.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.9 | 10.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.9 | 13.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.9 | 16.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.9 | 0.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.9 | 6.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.9 | 11.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.9 | 10.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.9 | 2.7 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.9 | 15.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.9 | 4.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.9 | 52.1 | GO:0000791 | euchromatin(GO:0000791) |
0.9 | 4.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.8 | 1.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.8 | 12.7 | GO:0042611 | MHC protein complex(GO:0042611) |
0.8 | 4.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.8 | 361.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.8 | 3.3 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.8 | 2.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.8 | 27.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.8 | 0.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.8 | 4.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.8 | 6.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.8 | 8.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.8 | 6.4 | GO:0038201 | TOR complex(GO:0038201) |
0.8 | 9.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.8 | 1.6 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.8 | 2.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.8 | 4.6 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.8 | 4.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 14.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.8 | 5.4 | GO:0045120 | pronucleus(GO:0045120) |
0.8 | 7.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 10.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.7 | 7.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.7 | 1.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.7 | 133.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.7 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.7 | 1.5 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.7 | 23.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.7 | 5.9 | GO:0010369 | chromocenter(GO:0010369) |
0.7 | 12.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 7.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.7 | 8.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.7 | 39.0 | GO:0005844 | polysome(GO:0005844) |
0.7 | 12.6 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.7 | 7.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 203.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.7 | 18.7 | GO:0005902 | microvillus(GO:0005902) |
0.7 | 1.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.7 | 3.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.7 | 6.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.7 | 61.7 | GO:0016605 | PML body(GO:0016605) |
0.7 | 7.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.7 | 14.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.7 | 58.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.7 | 2.0 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.7 | 3.3 | GO:0000938 | GARP complex(GO:0000938) |
0.7 | 67.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.7 | 2.0 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.7 | 2.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.6 | 13.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 12.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 1.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.6 | 1.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.6 | 4.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.6 | 17.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.6 | 3.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.6 | 2.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.6 | 3.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.6 | 2.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.6 | 11.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.6 | 20.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.6 | 1.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.6 | 4.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 1.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 1.7 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.6 | 6.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.6 | 9.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.6 | 1.7 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.6 | 2.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.6 | 9.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.6 | 6.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.6 | 10.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.6 | 3.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.5 | 5.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.5 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.5 | 15.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 8.7 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.5 | 6.5 | GO:0034709 | methylosome(GO:0034709) |
0.5 | 3.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 22.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.5 | 43.2 | GO:0000785 | chromatin(GO:0000785) |
0.5 | 21.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.5 | 2.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.5 | 16.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.5 | 27.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.5 | 2.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 3.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 7.2 | GO:0031902 | late endosome membrane(GO:0031902) |
0.5 | 2.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.5 | 3.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 0.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.5 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 3.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 3.4 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 1.0 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.5 | 2.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 10.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 3.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 2.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 8.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 0.9 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.5 | 1.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 5.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.5 | 3.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 11.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 6.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.4 | 67.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 45.6 | GO:0036126 | sperm flagellum(GO:0036126) |
0.4 | 9.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 1.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 39.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 0.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 11.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 12.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 2.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 2.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 20.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.4 | 2.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.4 | 182.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 50.6 | GO:0005903 | brush border(GO:0005903) |
0.4 | 3.4 | GO:0001741 | XY body(GO:0001741) |
0.4 | 18.9 | GO:0031514 | motile cilium(GO:0031514) |
0.4 | 2.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 7.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.4 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 56.8 | GO:0001726 | ruffle(GO:0001726) |
0.4 | 14.3 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 9.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 2.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 3.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 9.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 1.4 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 2.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 5.8 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 3.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 35.4 | GO:0005819 | spindle(GO:0005819) |
0.3 | 2.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 6.8 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 1.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 4.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 16.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 26.8 | GO:0005814 | centriole(GO:0005814) |
0.3 | 11.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 1.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.0 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.3 | 2.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.3 | 1.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.3 | 55.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.3 | 110.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 1.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 7.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.3 | 4.9 | GO:0034399 | nuclear periphery(GO:0034399) |
0.3 | 0.3 | GO:0034455 | t-UTP complex(GO:0034455) |
0.3 | 4.2 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.3 | 73.1 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.3 | 0.8 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.3 | 10.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 7.1 | GO:0043034 | costamere(GO:0043034) |
0.3 | 1.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 0.5 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.3 | 1.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 3.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 6.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 2.8 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 1.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 1.2 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.2 | 4.1 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 58.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 1.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 9.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 3.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 2.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 1.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 0.7 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.2 | 40.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.2 | 4.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.2 | 11.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 1.2 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 7.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 4.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 6.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 6.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 1.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 15.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 57.0 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 1.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.5 | GO:0043291 | RAVE complex(GO:0043291) |
0.2 | 0.8 | GO:0031251 | PAN complex(GO:0031251) |
0.2 | 2.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.5 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 15.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 5.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 25.5 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 2.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.2 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 5.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 0.2 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 1.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 96.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.2 | GO:0034448 | EGO complex(GO:0034448) |
0.1 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 234.6 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 7.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 0.5 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.3 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.0 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.5 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.8 | 58.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
8.4 | 16.9 | GO:0048030 | disaccharide binding(GO:0048030) |
8.0 | 48.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
7.9 | 31.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
7.8 | 23.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
7.6 | 22.7 | GO:1902121 | lithocholic acid binding(GO:1902121) |
6.9 | 20.6 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
6.0 | 53.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
5.8 | 34.9 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
5.2 | 26.0 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
5.1 | 36.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
4.8 | 33.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
4.7 | 18.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
4.5 | 85.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
4.4 | 4.4 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
4.3 | 17.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
4.3 | 21.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
4.3 | 12.8 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
4.3 | 12.8 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-3 binding(GO:0019978) |
4.2 | 17.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
4.2 | 29.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
4.1 | 28.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
4.0 | 24.2 | GO:0005499 | vitamin D binding(GO:0005499) |
4.0 | 79.9 | GO:0044548 | S100 protein binding(GO:0044548) |
4.0 | 15.9 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
4.0 | 27.7 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
3.9 | 11.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
3.9 | 19.4 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
3.9 | 11.6 | GO:0070773 | protein-N-terminal glutamine amidohydrolase activity(GO:0070773) |
3.8 | 11.3 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
3.7 | 26.1 | GO:1990254 | keratin filament binding(GO:1990254) |
3.6 | 18.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
3.6 | 10.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
3.6 | 81.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
3.5 | 10.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
3.5 | 3.5 | GO:1990763 | arrestin family protein binding(GO:1990763) |
3.4 | 10.2 | GO:0032090 | Pyrin domain binding(GO:0032090) |
3.4 | 23.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
3.3 | 10.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
3.2 | 9.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
3.2 | 9.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
3.1 | 24.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
3.1 | 39.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.0 | 12.1 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
3.0 | 26.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
3.0 | 17.8 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
2.9 | 17.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
2.9 | 8.7 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
2.9 | 8.7 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
2.9 | 8.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
2.8 | 2.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
2.8 | 11.3 | GO:0045159 | myosin II binding(GO:0045159) |
2.8 | 36.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.8 | 28.0 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
2.8 | 14.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
2.8 | 11.2 | GO:0051435 | BH4 domain binding(GO:0051435) |
2.8 | 19.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.8 | 11.0 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
2.7 | 16.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.7 | 16.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.7 | 18.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
2.6 | 10.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.6 | 13.2 | GO:0048495 | Roundabout binding(GO:0048495) |
2.6 | 7.9 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
2.6 | 13.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.6 | 7.9 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
2.6 | 23.2 | GO:0038132 | neuregulin binding(GO:0038132) |
2.5 | 12.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
2.5 | 7.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.5 | 12.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
2.5 | 7.6 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
2.5 | 12.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.5 | 54.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.5 | 17.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
2.5 | 22.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
2.5 | 9.8 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
2.4 | 4.8 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
2.4 | 7.2 | GO:0003999 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
2.4 | 11.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.4 | 7.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) BLOC-2 complex binding(GO:0036461) |
2.4 | 9.5 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
2.4 | 141.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.3 | 9.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
2.3 | 13.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
2.3 | 20.7 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
2.3 | 6.9 | GO:0003896 | DNA primase activity(GO:0003896) |
2.3 | 6.8 | GO:0001761 | beta-alanine transmembrane transporter activity(GO:0001761) taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
2.2 | 108.2 | GO:0003785 | actin monomer binding(GO:0003785) |
2.2 | 15.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
2.2 | 15.4 | GO:0043515 | kinetochore binding(GO:0043515) |
2.2 | 8.8 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
2.1 | 25.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.1 | 6.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
2.1 | 14.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
2.1 | 2.1 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) |
2.1 | 16.9 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
2.1 | 4.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
2.1 | 6.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
2.1 | 78.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
2.1 | 8.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
2.0 | 8.2 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
2.0 | 8.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
2.0 | 26.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
2.0 | 14.0 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
2.0 | 36.0 | GO:0043495 | protein anchor(GO:0043495) |
2.0 | 11.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
2.0 | 11.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
2.0 | 7.9 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
2.0 | 11.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
2.0 | 25.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.9 | 5.8 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
1.9 | 5.8 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
1.9 | 3.9 | GO:0070976 | TIR domain binding(GO:0070976) |
1.9 | 3.9 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
1.9 | 15.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.9 | 36.3 | GO:0038191 | neuropilin binding(GO:0038191) |
1.9 | 13.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.9 | 5.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.9 | 17.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.9 | 16.8 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.9 | 11.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.9 | 7.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.8 | 5.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.8 | 7.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.8 | 21.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.8 | 7.1 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.8 | 7.1 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
1.8 | 3.5 | GO:0034046 | poly(G) binding(GO:0034046) |
1.7 | 5.2 | GO:0052598 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
1.7 | 5.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.7 | 27.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.7 | 13.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.7 | 12.1 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
1.7 | 3.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
1.7 | 5.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
1.7 | 8.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.7 | 8.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
1.7 | 5.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
1.7 | 43.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.6 | 1.6 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
1.6 | 1.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
1.6 | 14.6 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.6 | 4.8 | GO:0030519 | snoRNP binding(GO:0030519) |
1.6 | 7.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.6 | 9.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.6 | 14.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.6 | 17.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.6 | 20.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.5 | 10.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.5 | 7.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.5 | 10.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.5 | 24.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.5 | 6.1 | GO:0032357 | oxidized purine DNA binding(GO:0032357) |
1.5 | 15.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.5 | 4.5 | GO:0070122 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
1.5 | 9.1 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.5 | 7.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.5 | 4.5 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
1.5 | 6.0 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
1.5 | 10.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.5 | 22.2 | GO:0031996 | thioesterase binding(GO:0031996) |
1.5 | 7.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.5 | 17.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.5 | 26.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
1.5 | 13.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.5 | 8.8 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
1.5 | 4.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.5 | 11.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.5 | 16.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.5 | 7.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.4 | 5.8 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
1.4 | 4.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.4 | 13.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.4 | 5.7 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
1.4 | 38.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.4 | 4.3 | GO:0002113 | interleukin-33 binding(GO:0002113) |
1.4 | 2.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.4 | 7.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.4 | 42.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.4 | 4.3 | GO:0016872 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
1.4 | 26.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.4 | 1.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.4 | 11.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
1.4 | 21.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.4 | 4.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
1.4 | 4.2 | GO:0090556 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.4 | 16.6 | GO:0050700 | CARD domain binding(GO:0050700) |
1.4 | 15.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.4 | 15.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.4 | 13.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.4 | 1.4 | GO:0035877 | death effector domain binding(GO:0035877) |
1.4 | 12.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.4 | 8.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.4 | 12.2 | GO:0045545 | syndecan binding(GO:0045545) |
1.4 | 2.7 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
1.4 | 4.1 | GO:0015389 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
1.3 | 17.5 | GO:0042731 | PH domain binding(GO:0042731) |
1.3 | 18.8 | GO:1990405 | protein antigen binding(GO:1990405) |
1.3 | 9.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
1.3 | 12.0 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
1.3 | 2.6 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
1.3 | 26.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.3 | 18.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.3 | 3.9 | GO:0033149 | FFAT motif binding(GO:0033149) |
1.3 | 6.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.3 | 7.8 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
1.3 | 2.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.3 | 17.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.3 | 83.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.3 | 17.7 | GO:0031386 | protein tag(GO:0031386) |
1.3 | 3.8 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
1.3 | 1.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
1.3 | 22.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.2 | 2.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.2 | 14.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.2 | 6.2 | GO:0030911 | TPR domain binding(GO:0030911) |
1.2 | 4.9 | GO:0008147 | structural constituent of bone(GO:0008147) |
1.2 | 8.6 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) steroid sulfotransferase activity(GO:0050294) |
1.2 | 297.3 | GO:0051015 | actin filament binding(GO:0051015) |
1.2 | 1.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.2 | 25.2 | GO:0001968 | fibronectin binding(GO:0001968) |
1.2 | 4.8 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
1.2 | 22.7 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
1.2 | 8.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.2 | 2.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
1.2 | 4.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.2 | 32.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.2 | 23.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.2 | 11.7 | GO:0071253 | connexin binding(GO:0071253) |
1.2 | 4.7 | GO:0019809 | spermidine binding(GO:0019809) |
1.2 | 5.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.2 | 16.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
1.2 | 17.5 | GO:0005522 | profilin binding(GO:0005522) |
1.2 | 4.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.2 | 3.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.2 | 3.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.2 | 4.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.2 | 5.8 | GO:0034618 | arginine binding(GO:0034618) |
1.2 | 13.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.2 | 1.2 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
1.2 | 4.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
1.1 | 13.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
1.1 | 9.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.1 | 11.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
1.1 | 3.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.1 | 9.0 | GO:0016936 | galactoside binding(GO:0016936) |
1.1 | 56.4 | GO:0050699 | WW domain binding(GO:0050699) |
1.1 | 29.5 | GO:0001618 | virus receptor activity(GO:0001618) |
1.1 | 2.2 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
1.1 | 3.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.1 | 10.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.1 | 11.9 | GO:0046977 | TAP binding(GO:0046977) |
1.1 | 1.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.1 | 21.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.1 | 4.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.1 | 18.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.1 | 31.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.1 | 11.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.1 | 79.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.1 | 3.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.1 | 11.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.0 | 8.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.0 | 9.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.0 | 8.4 | GO:0017040 | ceramidase activity(GO:0017040) |
1.0 | 2.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.0 | 16.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.0 | 6.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.0 | 3.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
1.0 | 3.1 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
1.0 | 4.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.0 | 51.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.0 | 3.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.0 | 16.2 | GO:0070513 | death domain binding(GO:0070513) |
1.0 | 7.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.0 | 6.1 | GO:0070728 | leucine binding(GO:0070728) |
1.0 | 12.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.0 | 3.0 | GO:0035939 | microsatellite binding(GO:0035939) |
1.0 | 6.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.0 | 5.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
1.0 | 5.0 | GO:0034061 | DNA polymerase activity(GO:0034061) |
1.0 | 3.0 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
1.0 | 13.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.0 | 5.9 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.0 | 9.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
1.0 | 12.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.0 | 2.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.0 | 11.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.0 | 6.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.0 | 2.9 | GO:0015925 | alpha-galactosidase activity(GO:0004557) alpha-N-acetylgalactosaminidase activity(GO:0008456) galactosidase activity(GO:0015925) |
1.0 | 8.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.0 | 9.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.0 | 6.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
1.0 | 16.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.9 | 5.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.9 | 3.7 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.9 | 2.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.9 | 23.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.9 | 3.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.9 | 0.9 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.9 | 15.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.9 | 6.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.9 | 2.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.9 | 1.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.9 | 5.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.9 | 3.6 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.9 | 2.7 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.9 | 5.3 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.9 | 7.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.9 | 3.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.9 | 1.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.9 | 9.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.9 | 14.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.9 | 9.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.9 | 4.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.9 | 7.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.9 | 15.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.9 | 33.0 | GO:0045182 | translation regulator activity(GO:0045182) |
0.9 | 32.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 7.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.9 | 15.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.9 | 1.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.9 | 4.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.9 | 2.6 | GO:0019202 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.9 | 0.9 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.8 | 67.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.8 | 1.7 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.8 | 0.8 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.8 | 0.8 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.8 | 28.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.8 | 7.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.8 | 5.8 | GO:0031432 | titin binding(GO:0031432) |
0.8 | 14.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.8 | 3.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.8 | 6.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.8 | 5.8 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.8 | 21.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.8 | 3.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.8 | 5.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.8 | 18.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.8 | 5.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.8 | 1.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 5.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.8 | 16.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.8 | 21.7 | GO:0035173 | histone kinase activity(GO:0035173) |
0.8 | 2.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.8 | 3.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.8 | 10.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.8 | 4.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 2.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.8 | 2.4 | GO:0070540 | stearic acid binding(GO:0070540) |
0.8 | 17.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.8 | 17.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.8 | 7.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.8 | 2.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.8 | 2.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.8 | 9.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 6.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.8 | 2.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.8 | 4.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.8 | 2.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.8 | 3.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.8 | 4.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 42.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.8 | 2.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.8 | 2.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.8 | 32.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.8 | 0.8 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.8 | 3.0 | GO:0032810 | sterol response element binding(GO:0032810) |
0.7 | 4.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.7 | 3.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 3.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.7 | 5.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.7 | 19.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.7 | 2.9 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.7 | 65.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.7 | 5.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 2.2 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.7 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.7 | 16.6 | GO:0051861 | glycolipid binding(GO:0051861) |
0.7 | 2.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.7 | 1.4 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.7 | 12.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.7 | 4.3 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.7 | 3.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.7 | 2.8 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.7 | 5.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.7 | 5.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.7 | 4.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.7 | 15.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.7 | 2.8 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.7 | 18.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.7 | 12.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.7 | 2.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.7 | 168.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.7 | 6.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.7 | 10.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.7 | 6.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.7 | 9.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.7 | 5.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.7 | 3.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.7 | 0.7 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.7 | 4.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.7 | 10.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.7 | 17.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.7 | 4.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.7 | 1.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.7 | 4.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.7 | 3.3 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.7 | 2.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.7 | 3.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.7 | 7.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 3.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.7 | 5.2 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.7 | 9.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.6 | 5.2 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 1.3 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.6 | 16.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.6 | 10.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.6 | 117.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.6 | 8.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 1.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.6 | 1.3 | GO:0036004 | GAF domain binding(GO:0036004) |
0.6 | 3.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.6 | 16.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.6 | 8.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.6 | 1.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.6 | 17.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 13.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.6 | 0.6 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.6 | 12.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.6 | 48.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.6 | 1.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.6 | 3.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.6 | 33.9 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.6 | 2.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.6 | 3.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.6 | 4.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 11.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.6 | 4.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.6 | 31.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.6 | 5.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.6 | 2.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 3.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 4.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 59.6 | GO:0042393 | histone binding(GO:0042393) |
0.6 | 13.9 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.6 | 18.0 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.6 | 2.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.6 | 12.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 8.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.6 | 1.1 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.6 | 2.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 18.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 2.7 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.5 | 28.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.5 | 2.2 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.5 | 2.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 2.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 13.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 11.8 | GO:0019956 | chemokine binding(GO:0019956) |
0.5 | 7.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.5 | 1.6 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.5 | 2.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 3.2 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.5 | 5.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 11.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 3.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 23.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.5 | 1.6 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.5 | 1.6 | GO:0031208 | POZ domain binding(GO:0031208) |
0.5 | 161.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 1.5 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
0.5 | 11.3 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.5 | 3.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 6.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.5 | 14.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.5 | 1.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 2.0 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.5 | 64.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.5 | 1.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 16.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 3.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.5 | 8.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 3.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.5 | 9.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 1.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 0.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.5 | 4.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.5 | 3.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.5 | 2.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 2.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.5 | 3.3 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.5 | 4.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 3.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.5 | 5.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.5 | 1.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.5 | 3.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 3.7 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 1.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 3.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 7.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.5 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 2.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.4 | 9.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.4 | 2.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 2.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 2.7 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.4 | 1.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 4.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.4 | 16.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.4 | 38.2 | GO:0004386 | helicase activity(GO:0004386) |
0.4 | 2.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.4 | 4.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.4 | 3.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 0.4 | GO:0003681 | bent DNA binding(GO:0003681) |
0.4 | 0.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 15.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.4 | 4.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 33.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.4 | 3.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.4 | 6.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 11.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 5.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 0.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.4 | 7.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 4.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 2.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 4.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.4 | 9.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.4 | 1.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 21.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.4 | 12.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.4 | 3.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.4 | 13.6 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.4 | 4.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 17.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.4 | 1.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 1.1 | GO:0052742 | phosphatidylinositol 3-kinase activity(GO:0035004) phosphatidylinositol kinase activity(GO:0052742) |
0.4 | 1.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.4 | 8.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 9.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.4 | 59.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 3.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 2.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 1.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.4 | 2.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.4 | 13.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.4 | 1.8 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.4 | 1.8 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
0.4 | 131.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.4 | 79.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 1.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 2.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.4 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 10.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 14.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 1.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 14.8 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.4 | 21.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 5.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 9.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 8.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 13.8 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 1.7 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.3 | 1.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 1.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 10.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 12.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 6.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 0.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.3 | 1.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 11.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.3 | 2.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.9 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.0 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.3 | 3.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.9 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.3 | 7.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.3 | 0.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 0.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 11.2 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 2.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 1.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 8.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 0.9 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.3 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 1.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 0.9 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.3 | 4.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 5.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 9.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 1.4 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.3 | 0.8 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) N-acetylglucosamine kinase activity(GO:0045127) |
0.3 | 1.4 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.3 | 42.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.3 | 3.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 2.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 0.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.3 | 2.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 2.2 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 1.6 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 0.8 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.3 | 33.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 1.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 4.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 5.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 9.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 2.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 7.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 0.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.3 | 0.3 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.3 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 109.7 | GO:0001067 | regulatory region nucleic acid binding(GO:0001067) |
0.2 | 2.2 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.2 | 2.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 1.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 6.5 | GO:0046332 | SMAD binding(GO:0046332) |
0.2 | 1.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 21.7 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 1.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 1.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 3.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 2.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.2 | 1.7 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 1.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 1.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.9 | GO:0004335 | galactokinase activity(GO:0004335) |
0.2 | 1.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.7 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.2 | 0.7 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.2 | 2.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.7 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.2 | 0.7 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.2 | 4.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 69.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 0.9 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.2 | 8.9 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 3.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 1.3 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 1.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 1.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.6 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.2 | 1.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 4.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 6.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 4.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 1.0 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 1.7 | GO:0016160 | amylase activity(GO:0016160) |
0.2 | 3.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 1.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 12.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 0.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 0.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 1.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.5 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.2 | 8.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 4.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 11.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.2 | 0.2 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.2 | 19.0 | GO:0019902 | phosphatase binding(GO:0019902) |
0.2 | 1.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.2 | 4.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 2.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.2 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 1.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 2.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.1 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.4 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.1 | 2.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 5.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 3.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.1 | 1.2 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 93.9 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 2.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.3 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.1 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.1 | 0.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.2 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 1.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.3 | GO:0018169 | ribosomal S6-glutamic acid ligase activity(GO:0018169) |
0.1 | 4.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 1.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 2.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.9 | GO:0042288 | MHC protein binding(GO:0042287) MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.2 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.1 | 0.1 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.1 | 2.7 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.0 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
0.0 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 8.2 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.2 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.0 | 4.0 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 1.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0070401 | NADP+ binding(GO:0070401) |
0.0 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 4.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 29.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
2.9 | 166.1 | PID AURORA B PATHWAY | Aurora B signaling |
2.8 | 27.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
2.8 | 52.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
2.7 | 2.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
2.4 | 39.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.3 | 74.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.3 | 69.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
2.2 | 38.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.1 | 42.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.1 | 4.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.1 | 14.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
2.0 | 165.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.9 | 109.1 | PID PLK1 PATHWAY | PLK1 signaling events |
1.9 | 162.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.9 | 22.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.9 | 60.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.9 | 113.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.8 | 5.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.7 | 57.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.7 | 11.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.6 | 6.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.6 | 41.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.5 | 56.9 | PID EPO PATHWAY | EPO signaling pathway |
1.5 | 9.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.5 | 59.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.5 | 55.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.4 | 20.3 | ST STAT3 PATHWAY | STAT3 Pathway |
1.4 | 85.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.4 | 21.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.4 | 2.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.4 | 34.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.3 | 64.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.3 | 1.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.3 | 2.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.3 | 5.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.2 | 18.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.2 | 4.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.2 | 55.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.2 | 37.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.2 | 62.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.1 | 34.4 | PID RAS PATHWAY | Regulation of Ras family activation |
1.1 | 68.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.1 | 11.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.1 | 45.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
1.1 | 27.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.0 | 26.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.0 | 24.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.0 | 19.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.0 | 28.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.0 | 19.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.0 | 25.0 | PID ARF6 PATHWAY | Arf6 signaling events |
1.0 | 23.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.0 | 4.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.9 | 19.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.9 | 16.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.9 | 5.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.9 | 21.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.9 | 19.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.9 | 27.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.9 | 54.7 | PID E2F PATHWAY | E2F transcription factor network |
0.9 | 2.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.9 | 22.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.9 | 68.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.9 | 20.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.9 | 90.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.8 | 32.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.8 | 3.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.8 | 14.5 | PID ATR PATHWAY | ATR signaling pathway |
0.8 | 15.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 11.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.8 | 31.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.7 | 19.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.7 | 2.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.7 | 34.2 | PID BMP PATHWAY | BMP receptor signaling |
0.7 | 16.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.7 | 39.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.7 | 16.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.7 | 33.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.7 | 2.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.7 | 37.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 5.2 | PID ATM PATHWAY | ATM pathway |
0.6 | 21.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.6 | 5.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.6 | 50.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.6 | 12.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 4.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.6 | 59.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 26.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.6 | 3.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 18.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.6 | 8.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.6 | 8.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.6 | 18.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.6 | 30.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.6 | 27.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.6 | 17.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 12.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.6 | 3.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 2.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 1.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 9.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 7.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.5 | 5.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 94.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 7.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 12.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 1.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 5.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 6.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 2.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 11.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 6.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 17.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 1.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 2.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 10.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 3.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 8.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.3 | 1.7 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 5.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 4.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 2.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 5.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 54.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 3.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 2.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 8.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 2.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 42.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 3.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 10.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 74.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
4.5 | 4.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
4.2 | 41.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
3.6 | 46.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
3.2 | 3.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
3.1 | 40.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
2.6 | 81.7 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
2.6 | 23.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
2.5 | 25.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.4 | 57.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.4 | 16.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
2.3 | 42.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
2.3 | 4.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
2.3 | 27.5 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
2.3 | 49.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
2.1 | 107.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
2.0 | 26.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
2.0 | 2.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.9 | 19.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.9 | 99.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.9 | 34.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.9 | 45.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
1.9 | 1.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.9 | 39.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.9 | 26.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
1.8 | 12.8 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
1.8 | 35.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.8 | 5.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.7 | 3.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.7 | 43.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.7 | 21.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.7 | 25.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.7 | 71.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.7 | 13.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
1.6 | 49.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.6 | 9.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.6 | 8.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.5 | 44.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.5 | 54.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.5 | 57.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.5 | 7.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.5 | 59.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.5 | 148.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.4 | 2.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.4 | 1.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.4 | 1.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.4 | 14.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.4 | 32.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.4 | 43.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.4 | 30.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.4 | 56.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.4 | 94.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
1.3 | 13.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.3 | 157.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.3 | 21.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.3 | 14.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.3 | 14.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.3 | 6.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.3 | 59.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.3 | 3.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.3 | 3.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.3 | 58.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.3 | 17.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.3 | 8.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.3 | 11.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
1.2 | 24.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.2 | 17.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.2 | 36.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.1 | 5.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
1.1 | 12.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.1 | 8.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.1 | 53.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
1.1 | 34.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.1 | 28.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
1.1 | 1.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.0 | 5.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.0 | 10.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.0 | 36.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.0 | 19.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.0 | 16.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.0 | 9.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.9 | 17.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.9 | 14.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.9 | 1.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.9 | 1.8 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.8 | 1.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.8 | 2.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.8 | 11.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.8 | 12.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.8 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.8 | 17.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.8 | 14.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.8 | 3.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.8 | 3.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.8 | 3.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.7 | 2.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.7 | 55.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.7 | 5.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.7 | 14.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.7 | 19.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.7 | 10.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.7 | 7.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.7 | 15.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.7 | 104.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.7 | 25.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.7 | 20.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.7 | 3.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.7 | 16.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 23.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 12.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.7 | 15.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.7 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 9.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 18.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.6 | 1.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 20.5 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.6 | 12.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 16.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 2.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 41.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 7.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 24.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.6 | 14.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.6 | 1.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.6 | 28.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 10.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.6 | 73.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.6 | 3.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.6 | 18.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 11.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 13.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 18.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 8.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.5 | 4.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.5 | 6.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.5 | 25.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 12.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 1.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.5 | 19.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.5 | 5.4 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 4.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 7.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.5 | 0.9 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.4 | 3.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.4 | 14.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 14.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 8.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 8.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.4 | 3.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.4 | 25.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.4 | 0.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 15.6 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.4 | 4.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.4 | 8.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.4 | 23.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.4 | 1.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 2.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 4.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 10.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.3 | 27.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 7.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 6.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 2.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 4.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 1.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 16.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 9.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 3.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 1.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.3 | 3.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 2.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 5.7 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.3 | 0.8 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |
0.3 | 54.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 4.1 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.2 | 12.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 5.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 7.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 11.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 10.5 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.2 | 5.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 1.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 3.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 20.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 2.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 23.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 3.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 6.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 1.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 15.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 6.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 6.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 3.9 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 1.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 7.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 6.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 3.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 4.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 8.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 4.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.6 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.7 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 1.2 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 4.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.5 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 4.5 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 1.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |